<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1287" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1287/" /><meta name="ncbi_pagename" content="Hermansky-Pudlak Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hermansky-Pudlak Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hermansky-Pudlak Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/10/26" /><meta name="citation_author" content="Marjan Huizing" /><meta name="citation_author" content="May Christine V Malicdan" /><meta name="citation_author" content="Bernadette R Gochuico" /><meta name="citation_author" content="William A Gahl" /><meta name="citation_pmid" content="20301464" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1287/" /><meta name="citation_keywords" content="AP-3 complex subunit beta-1" /><meta name="citation_keywords" content="AP-3 complex subunit delta-1" /><meta name="citation_keywords" content="Biogenesis of lysosome-related organelles complex 1 subunit 3" /><meta name="citation_keywords" content="Biogenesis of lysosome-related organelles complex 1 subunit 6" /><meta name="citation_keywords" content="Dysbindin" /><meta name="citation_keywords" content="Hermansky-Pudlak syndrome 1 protein" /><meta name="citation_keywords" content="Hermansky-Pudlak syndrome 3 protein" /><meta name="citation_keywords" content="Hermansky-Pudlak syndrome 4 protein" /><meta name="citation_keywords" content="Hermansky-Pudlak syndrome 5 protein" /><meta name="citation_keywords" content="Hermansky-Pudlak syndrome 6 protein" /><meta name="citation_keywords" content="AP3B1" /><meta name="citation_keywords" content="AP3D1" /><meta name="citation_keywords" content="BLOC1S3" /><meta name="citation_keywords" content="BLOC1S6" /><meta name="citation_keywords" content="DTNBP1" /><meta name="citation_keywords" content="HPS1" /><meta name="citation_keywords" content="HPS3" /><meta name="citation_keywords" content="HPS4" /><meta name="citation_keywords" content="HPS5" /><meta name="citation_keywords" content="HPS6" /><meta name="citation_keywords" content="Hermansky-Pudlak Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hermansky-Pudlak Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marjan Huizing" /><meta name="DC.Contributor" content="May Christine V Malicdan" /><meta name="DC.Contributor" content="Bernadette R Gochuico" /><meta name="DC.Contributor" content="William A Gahl" /><meta name="DC.Date" content="2017/10/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1287/" /><meta name="description" content="Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1." /><meta name="og:title" content="Hermansky-Pudlak Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1287/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hps/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1287/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D20B2E0425EE100000000020E00C3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1287_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1287_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/taa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tay-sachs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1287_"><span class="title" itemprop="name">Hermansky-Pudlak Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Marjan Huizing</span>, PhD, <span itemprop="author">May Christine V Malicdan</span>, MD, PhD, <span itemprop="author">Bernadette R Gochuico</span>, MD, and <span itemprop="author">William A Gahl</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1287_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1287_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marjan Huizing</span>, PhD<div class="affiliation small">Staff Scientist, National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@gniziuhm" class="oemail">vog.hin.liam@gniziuhm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">May Christine V Malicdan</span>, MD, PhD<div class="affiliation small">Staff Scientist, National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin@nadcilam.enitsirhcyam" class="oemail">vog.hin@nadcilam.enitsirhcyam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bernadette R Gochuico</span>, MD<div class="affiliation small">Staff Clinician, National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@bciuhcog" class="oemail">vog.hin.liam@bciuhcog</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">William A Gahl</span>, MD, PhD<div class="affiliation small">Clinical Director, National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.xileh@lhagb" class="oemail">vog.hin.xileh@lhagb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 24, 2000</span>; Last Update: <span itemprop="dateModified">October 26, 2017</span>.</p><p><em>Estimated reading time: 36 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hps.Summary" itemprop="description"><h2 id="_hps_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in <i>AP3B1</i> and <i>AP3D1</i>.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HPS is established by clinical findings of hypopigmentation of the skin and hair, characteristic eye findings, and demonstration of absent delta granules (dense bodies) on whole-mount electron microscopy of platelets. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AP3B1</i>, <i>AP3D1</i>, <i>BLOC1S3</i>, <i>BLOC1S6</i>, <i>DTNBP1</i>, <i>HPS1,</i>
<i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, or <i>HPS6</i> confirms the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Correction of refractive errors and use of low vision aids; humidifier to reduce frequency of epistaxis; oral contraceptives can limit the duration of menstrual periods; thrombin-soaked gelfoam for skin wounds with prolonged bleeding; DDAVP (1-desamino-8-D-arginine vasopressin) for wisdom tooth extraction and invasive procedures; platelet or red blood cell transfusions for surgery or protracted bleeding; supplemental oxygen and, ultimately, lung transplantation for severe pulmonary disease; steroids, other anti-inflammatory agents, and/or Remicade<sup>&#x000ae;</sup> for granulomatous colitis. Immunodeficiency, when present, is granulocyte colony-stimulating factor (G-CSF) responsive.</p><p><i>Prevention of secondary complications:</i> Protection of the skin from the sun; wearing a medical alert bracelet that explicitly describes the functional platelet defect; maximizing pulmonary function before development of pulmonary fibrosis by prompt treatment of pulmonary infections, immunizing with influenza and pneumococcal vaccines, and regular moderate exercise.</p><p><i>Surveillance:</i> Annual ophthalmologic examination; at least annual examination of the skin for solar keratoses (premalignant lesions), basal cell carcinoma, squamous cell carcinoma; annual pulmonary function testing in those older than age 20 years; routine history for symptoms of colitis (e.g., cramping, increased mucus in the stool, rectal bleeding).</p><p><i>Agents/circumstances to avoid:</i> Aspirin-containing products; activities that increase the risk of bleeding; cigarette smoke; direct sun exposure.</p><p><i>Evaluation of relatives at risk:</i> In rare families with the milder types (<i>HPS3</i>, <i>HPS5</i>, and <i>HPS6</i>-related HPS), the evaluation of apparently unaffected sibs may yield a positive diagnosis.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>HPS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible for those families in which the pathogenic variants have been identified.</p></div></div><div id="hps.Diagnosis"><h2 id="_hps_Diagnosis_">Diagnosis</h2><div id="hps.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Hermansky-Pudlak syndrome (HPS) <b>should be suspected</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following clinical and laboratory features.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Nystagmus, wandering eye movements, lack of visual attention</div></li><li class="half_rhythm"><div>Skin and hair color lighter than that of other family members</div></li><li class="half_rhythm"><div>Prolonged bleeding after minor procedures (e.g., circumcision, tooth extraction), bruising, epistaxis, gingival bleeding</div></li></ul><p><b>Laboratory features (coagulation studies)</b></p><ul><li class="half_rhythm"><div>Platelet aggregation testing showing impaired secondary aggregation response</div></li><li class="half_rhythm"><div>Prothrombin time, partial thromboplastin time, and platelet counts typically normal</div></li><li class="half_rhythm"><div>Bleeding time generally prolonged</div></li><li class="half_rhythm"><div>Absence of platelet delta granules (dense bodies) on whole mount electron microscopy</div></li></ul></div><div id="hps.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Hermansky-Pudlak syndrome (HPS) <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the clinical findings of oculocutaneous albinism in combination with the absence of platelet delta granules (dense bodies) on whole-mount electron microscopy (the <i>sine qua non</i> for HPS). Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud/?report=objectonly" target="object" rid-figpopup="fighpsTmoleculargeneticsofhermanskypud" rid-ob="figobhpsTmoleculargeneticsofhermanskypud">Table 1a</a> or <a class="figpopup" href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud_1/?report=objectonly" target="object" rid-figpopup="fighpsTmoleculargeneticsofhermanskypud1" rid-ob="figobhpsTmoleculargeneticsofhermanskypud1">Table 1b</a> confirms the diagnosis if clinical features are inconclusive, and allows for family studies.</p><div id="hps.Clinical_Findings"><h4>Clinical Findings</h4><p><b>Oculocutaneous albinism</b> is established by finding hypopigmentation of the skin and hair on physical examination associated with the following characteristic ocular findings:</p><ul><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Reduced iris pigment with iris transillumination</div></li><li class="half_rhythm"><div>Reduced retinal pigment on fundoscopic examination</div></li><li class="half_rhythm"><div>Foveal hypoplasia associated with significant reduction in visual acuity</div></li><li class="half_rhythm"><div>Increased crossing of the optic nerve fibers</div></li></ul><p><b>Absence of platelet delta granules (dense bodies)</b> is identified by electron microscopy (preferably "whole mount" as opposed to transmission) [<a class="bk_pop" href="#hps.REF.witkop.1989">Witkop et al 1989</a>]. On stimulation of platelets, the dense bodies, which contain ADP, ATP, serotonin, calcium, and phosphate, release their contents to attract other platelets. This process constitutes the secondary aggregation response, which cannot occur in the absence of the dense bodies. There are normally four to eight dense bodies per platelet; there are no dense bodies in the platelets of individuals with HPS.</p></div><div id="hps.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, or <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Targeted analysis for the <i>HPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1287/table/hps.T.hps1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps1pathogenicvariantsdiscussed" rid-ob="figobhpsThps1pathogenicvariantsdiscussed">c.1470_1486dup16</a> can be performed first in individuals of northwestern Puerto Rican ancestry.</p><p>Targeted analysis for the <i>HPS3</i> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant <a class="figpopup" href="/books/NBK1287/table/hps.T.hps3_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps3pathogenicvariantsdiscussed" rid-ob="figobhpsThps3pathogenicvariantsdiscussed">c.1163+1G&#x0003e;A</a> can be performed first in individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry.</p><p>Targeted analysis for the <i>HPS3</i>
<a class="figpopup" href="/books/NBK1287/table/hps.T.hps3_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps3pathogenicvariantsdiscussed" rid-ob="figobhpsThps3pathogenicvariantsdiscussed">g.339_4260del3904</a> variant (also referred to as the 3.9-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) can be performed first in individuals of central Puerto Rican ancestry.</p><p>For other individuals, the order of testing may be guided by the severity of clinical findings; visual acuity provides a rough measure of severity:</p><ul><li class="half_rhythm"><div>Sequence analysis of <i>HPS1</i> and <i>HPS4</i> can be considered first in severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (severe oculocutaneous albinism or signs of pulmonary fibrosis).</div></li><li class="half_rhythm"><div>Sequence analysis of <i>HPS3</i>, <i>HPS5</i>, and <i>HPS6</i> can be considered first in mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>If an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had neutropenia or infections as a child, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>AP3B1</i> and <i>AP3D1</i> should be considered first, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing if <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants are not identified.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>AP3B1</i>, <i>AP3D1, BLOC1S3</i>, <i>BLOC1S6, DTNBP1</i>, <i>HPS1</i>, <i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, <i>HPS6</i>, and other genes of interest (see <a href="#hps.Differential_Diagnosis">Differential Diagnosis</a>) can be considered. Note: (1) The genes included and the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. In some laboratories, panel options may include custom laboratory-designed panels and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying phenotype. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered particularly because of the large number of genes associated with HPS. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="hps.T.molecular_genetics_of_hermanskypud" class="table"><h3><span class="label">Table 1a. </span></h3><div class="caption"><p>Molecular Genetics of Hermansky-Pudlak Syndrome: Most Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.molecular_genetics_of_hermanskypud_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of HPS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2" id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Non-Puerto Rican&#x000a0;<sup>4</sup></th><th headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2" id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Puerto Rican&#x000a0;<sup>5</sup></th><th headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3" id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></th><th headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3" id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></th></tr></thead><tbody><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP3B1</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPS1</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~37%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~82%&#x000a0;<sup>9</sup></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPS3</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~12%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~20%&#x000a0;<sup>11</sup></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% of Puerto Ricans&#x000a0;<sup>11,&#x000a0;12</sup></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPS4</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~11.5%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>13</sup></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPS5</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~9%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>14</sup></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPS6</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~16.5%&#x000a0;<sup>15</sup></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_2 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">98%</td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_3 hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>16</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hps.TF.1a.1"><p class="no_margin">HGNC-approved <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbols, listed alphabetically. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p></div></dd><dt>2. </dt><dd><div id="hps.TF.1a.2"><p class="no_margin">See <a href="/books/NBK1287/#hps.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="hps.TF.1a.3"><p class="no_margin">See <a href="#hps.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="hps.TF.1a.4"><p class="no_margin">Based on approximately 278 individuals with HPS of non-Puerto Rican ancestry reported as of July 2017</p></div></dd><dt>5. </dt><dd><div id="hps.TF.1a.5"><p class="no_margin">Based on approximately 311 individuals with HPS of Puerto Rican ancestry reported as of July 2017</p></div></dd><dt>6. </dt><dd><div id="hps.TF.1a.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="hps.TF.1a.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="hps.TF.1a.8"><p class="no_margin"><a class="bk_pop" href="#hps.REF.jung.2006.362">Jung et al [2006]</a>, <a class="bk_pop" href="#hps.REF.wenham.2010.333">Wenham et al [2010]</a>, <a class="bk_pop" href="#hps.REF.jessen.2013.2943">Jessen et al [2013]</a>; a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 5 inversion with a breakpoint in <i>AP3B1</i> has also been reported [<a class="bk_pop" href="#hps.REF.jones.2013.42">Jones et al 2013</a>].</p></div></dd><dt>9. </dt><dd><div id="hps.TF.1a.9"><p class="no_margin">Homozygosity for the <i>HPS1</i>
<a class="figpopup" href="/books/NBK1287/table/hps.T.hps1_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps1pathogenicvariantsdiscussed" rid-ob="figobhpsThps1pathogenicvariantsdiscussed">c.1470_1486dup16</a> is found in approximately 80% of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of (northwest) Puerto Rican ancestry [<a class="bk_pop" href="#hps.REF.santiago_borrero.2006.85">Santiago Borrero et al 2006</a>].</p></div></dd><dt>10. </dt><dd><div id="hps.TF.1a.10"><p class="no_margin">A ~14-kb <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#hps.REF.griffin.2005.23">Griffin et al 2005</a>] and an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15-18 deletion [<a class="bk_pop" href="#hps.REF.wei.2016.702">Wei et al 2016</a>]</p></div></dd><dt>11. </dt><dd><div id="hps.TF.1a.11"><p class="no_margin"><a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al [2001]</a></p></div></dd><dt>12. </dt><dd><div id="hps.TF.1a.12"><p class="no_margin">Apart from the Puerto Rican 3.9-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, no other large insertions/deletions have been reported in <i>HPS3</i>.</p></div></dd><dt>13. </dt><dd><div id="hps.TF.1a.13"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>14. </dt><dd><div id="hps.TF.1a.14"><p class="no_margin">A 1.4-kb <i>HPS5</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> was reported in one individual [<a class="bk_pop" href="#hps.REF.michaud.2017.563">Michaud et al 2017</a>].</p></div></dd><dt>15. </dt><dd><div id="hps.TF.1a.15"><p class="no_margin">This includes 20 individuals of Israeli-Bedouin descent <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1287/table/hps.T.hps6_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps6pathogenicvariantsdiscussed" rid-ob="figobhpsThps6pathogenicvariantsdiscussed">c.1066_1067insG</a> <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> [<a class="bk_pop" href="#hps.REF.schreyershafir.2006.1158">Schreyer-Shafir et al 2006</a>].</p></div></dd><dt>16. </dt><dd><div id="hps.TF.1a.16"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> ~20-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>HPS6</i> has been identified in one individual [<a class="bk_pop" href="#hps.REF.huizing.2009.803">Huizing et al 2009</a>].</p></div></dd></dl></div></div></div><div id="hps.T.molecular_genetics_of_hermanskypud_1" class="table"><h3><span class="label">Table 1b. </span></h3><div class="caption"><p>Molecular Genetics of Hermansky-Pudlak Syndrome: Less Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.molecular_genetics_of_hermanskypud_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></th><th id="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP3D1</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#hps.REF.ammann.2016.997">Ammann et al [2016]</a></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLOC1S3</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#hps.REF.morgan.2006.160">Morgan et al [2006]</a>, <a class="bk_pop" href="#hps.REF.cullinane.2012.584">Cullinane et al [2012]</a></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLOC1S6</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#hps.REF.badolato.2012.3185">Badolato et al [2012]</a>, <a class="bk_pop" href="#hps.REF.yousaf.2016.231">Yousaf et al [2016]</a></td></tr><tr><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DTNBP1</i></td><td headers="hd_h_hps.T.molecular_genetics_of_hermanskypud_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#hps.REF.li.2003.84">Li et al [2003]</a>, <a class="bk_pop" href="#hps.REF.lowe.2013.766">Lowe et al [2013]</a>, <a class="bk_pop" href="#hps.REF.bryan.2017.378">Bryan et al [2017]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., they account for &#x0003c;1% of Hermansky-Pudlak syndrome).</p></div></dd><dt>1. </dt><dd><div id="hps.TF.1b.1"><p class="no_margin">HGNC-approved <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbols, listed alphabetically. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p></div></dd><dt>2. </dt><dd><div id="hps.TF.1b.2"><p class="no_margin">See <a href="/books/NBK1287/">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="hps.TF.1b.3"><p class="no_margin">Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for further information on the genes included in this table.</p></div></dd></dl></div></div></div></div></div></div><div id="hps.Clinical_Characteristics"><h2 id="_hps_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hps.Clinical_Description"><h3>Clinical Description</h3><p>Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and other organ involvement in specific subtypes [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>]. Signs and symptoms of oculocutaneous albinism in HPS are variable but visual acuity generally remains stable.</p><p><b>Eyes.</b> Nearly all children with the albinism of HPS have nystagmus at birth, often noticed by the parents in the delivery room and by the examining physician. Children with HPS may also have periodic alternating nystagmus [<a class="bk_pop" href="#hps.REF.gradstein.2005.369">Gradstein et al 2005</a>], wandering eye movements, and lack of visual attention. The initial diagnosis of albinism is sometimes made by the ophthalmologist.</p><p>The nystagmus can be very fast early in life, and generally slows with time, but nearly all individuals with albinism have nystagmus throughout their lives. The development of pigment in the iris or retina does not affect the nystagmus. Nystagmus is most noticeable when an individual is tired or anxious, and less marked when s/he is well rested and relaxed. Individuals with HPS have increased crossing of the optic nerve fibers [<a class="bk_pop" href="#hps.REF.king.2001">King et al 2001</a>].</p><p>Photophobia may accompany severe foveal hypoplasia.</p><p>Iris color may remain blue or change to a green/hazel or brown/tan color. Globe transillumination can be complete or can show peripupillary clumps or streaks of pigment in the iris that appear like spokes of a wagon wheel. Fine granular pigment may develop in the retina.</p><p>Visual acuity, usually between 20/50 and 20/400, is typically 20/200 and usually remains constant after early childhood [<a class="bk_pop" href="#hps.REF.iwata.2000.783">Iwata et al 2000</a>].</p><p>Alternating strabismus is found in many individuals with albinism and is generally not associated with the development of amblyopia.</p><p><b>Skin/hair.</b> The hair color ranges from white to brown, and can occasionally darken with age. Skin color can be white to olive, but is generally at least a shade lighter than that of other family members.</p><p>Over many years, exposure to the sun of lightly pigmented skin can result in coarse, rough, thickened skin (pachydermia), solar keratoses (premalignant lesions), and skin cancer. Both basal cell carcinoma and squamous cell carcinoma can develop. Although skin melanocytes are present in individuals with HPS, melanoma is rare.</p><p>Affected Puerto Ricans typically have solar damage manifesting as actinic keratoses and nevi. Ephelids, lentigines, and basal cell carcinoma also occur with increased frequency among Puerto Ricans with HPS [<a class="bk_pop" href="#hps.REF.toro.1999.774">Toro et al 1999</a>].</p><p><b>Bleeding diathesis.</b> The bleeding diathesis of HPS results from absent or severely deficient dense granules in platelets; the alpha granule contingent is normal [<a class="bk_pop" href="#hps.REF.huizing.2007.150">Huizing et al 2007</a>]. Affected individuals experience variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding during menstruation or after tooth extraction, circumcision, or other surgeries. Typically, cuts bleed longer than usual but heal normally. Bruising generally first appears at the time of ambulation. Epistaxis occurs in childhood and diminishes after adolescence. Menstrual cycles may be heavy and irregular. Prolonged bleeding after tooth extraction can lead to the diagnosis of HPS. Affected individuals with colitis may bleed excessively per rectum. Exsanguination as a complication of childbirth, trauma, or surgery is extremely rare.</p><p><b>Pulmonary fibrosis.</b> The fibrosis consists of progressive restrictive lung disease with an extremely variable time course [<a class="bk_pop" href="#hps.REF.gahl.2002.234">Gahl et al 2002</a>]. Symptoms usually begin in the thirties and are fatal within a decade. Pulmonary fibrosis has been described largely in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from northwestern Puerto Rico [<a class="bk_pop" href="#hps.REF.brantly.2000.129">Brantly et al 2000</a>, <a class="bk_pop" href="#hps.REF.avila.2002.887">Avila et al 2002</a>], but also occurs in other individuals with pathogenic variants in <i>HPS1</i>, <i>HPS4</i>, and <i>AP3B1</i> [<a class="bk_pop" href="#hps.REF.gochuico.2012.56">Gochuico et al 2012</a>]. To date, convincing evidence of pulmonary fibrosis has not been reported in affected individuals with pathogenic variants in other HPS-related genes (see <a class="figpopup" href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud/?report=objectonly" target="object" rid-figpopup="fighpsTmoleculargeneticsofhermanskypud" rid-ob="figobhpsTmoleculargeneticsofhermanskypud">Table 1a</a>, <a class="figpopup" href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud_1/?report=objectonly" target="object" rid-figpopup="fighpsTmoleculargeneticsofhermanskypud1" rid-ob="figobhpsTmoleculargeneticsofhermanskypud1">Table 1b</a>).</p><p><b>Colitis.</b> A bleeding granulomatous colitis resembling Crohn's disease presents on average at age 15 years, with wide variability [<a class="bk_pop" href="#hps.REF.gahl.1998.1258">Gahl et al 1998</a>]. The colitis is severe in 15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and occasionally requires colectomy; affected individuals may have the inflammatory bowel disease of HPS without the explicit diagnosis of colitis. Objective signs of colitis have been found primarily in persons with pathogenic variants in <i>HPS1</i> or <i>HPS4</i> [<a class="bk_pop" href="#hps.REF.hussain.2006.73">Hussain et al 2006</a>]. Although the colon is primarily involved in HPS, any part of the alimentary tract, including the gingiva, can be affected.</p><p><b>Neutropenia.</b> Neutropenia and/or immune defects have been associated with AP-3-deficient HPS, including individuals with pathogenic variants in <i>AP3B1</i> [<a class="bk_pop" href="#hps.REF.fontana.2006.4857">Fontana et al 2006</a>, <a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>] or <i>AP3D1</i> [<a class="bk_pop" href="#hps.REF.ammann.2016.997">Ammann et al 2016</a>].</p><p><b>Other.</b> Cardiomyopathy and renal failure have also been reported in individuals with HPS [<a class="bk_pop" href="#hps.REF.witkop.1989">Witkop et al 1989</a>].</p><p><b>Pathogenesis.</b> The mechanism of pulmonary fibrosis, granulomatous colitis, cardiomyopathy, and renal failure remains unknown. It is likely associated with aberrant biogenesis of lysosome-related organelles in specialized cells [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>]. Ceroid lipofuscin, a poorly defined, amorphous, granular, electron-dense, autofluorescent lipid-protein material, has been found to accumulate in the lysosomes of HPS cells, including renal tubular cells, alveolar macrophages, and cells of the gastrointestinal tract, bone marrow, liver, spleen, lymph nodes, and heart. The clinical consequences of lipofuscin accumulation in HPS remain greatly unexplored, as does the underlying cellular cause [<a class="bk_pop" href="#hps.REF.gahl.1998.1258">Gahl et al 1998</a>].</p></div><div id="hps.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>All individuals with HPS exhibit oculocutaneous albinism (due to aberrant melanosome formation) and a bleeding diathesis (due to absent platelet delta granules). Other clinical features occur per subtype and are listed below; individuals with pathogenic variants in the same HPS protein complex of AP-3, BLOC-1, BLOC-2, or BLOC-3 exhibit similar clinical characteristics [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>]. These complexes are described in <a href="#hps.Molecular_Pathogenesis">Molecular Pathogenesis</a>.</p><div id="hps.AP3B1_AP3D1_AP3_Deficiency"><h4><i>AP3B1, AP3D1</i> (AP-3 Deficiency)</h4><p>As of July 2017, 30 individuals with pathogenic variants in <i>AP3B1</i> or <i>AP3D1</i> have been reported. These individuals differ from those with other forms of HPS in that they exhibit immunodeficiency. They have an increased susceptibility to infections due to <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and impaired NK-cell cytotoxicity. It has been suggested that the neutropenia is caused by mislocalization of granule proteins in neutrophils [<a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>], including elastase [<a class="bk_pop" href="#hps.REF.di_pietro.2006.4027">Di Pietro et al 2006</a>, <a class="bk_pop" href="#hps.REF.jung.2006.362">Jung et al 2006</a>].</p><p>The one individual reported with <i>AP3D1-</i>related HPS, a boy of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Turkish parents, also exhibited neurodevelopmental delay, generalized seizures, and impaired hearing, features not commonly seen in individuals with <i>AP3B1</i>-related HPS. The boy died at age 3.5 years of septic pneumonia [<a class="bk_pop" href="#hps.REF.ammann.2016.997">Ammann et al 2016</a>]. See <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">Less Common Genetic Causes</a>, <b><i>AP3D1</i></b> (pdf) for variant details.</p></div><div id="hps.BLOC1S3_BLOC1S6_DTNBP1_BLOC1_Deficie"><h4><i>BLOC1S3</i>, <i>BLOC1S6, DTNBP1</i> (BLOC-1 Deficiency)</h4><p>As of July 2017, 12 individuals with pathogenic variants in <i>BLOC1S3</i>, <i>BLOC1S</i>6<i>,</i> or <i>DTNBP1</i> have been described [<a class="bk_pop" href="#hps.REF.li.2003.84">Li et al 2003</a>, <a class="bk_pop" href="#hps.REF.morgan.2006.160">Morgan et al 2006</a>, <a class="bk_pop" href="#hps.REF.badolato.2012.3185">Badolato et al 2012</a>, <a class="bk_pop" href="#hps.REF.cullinane.2012.584">Cullinane et al 2012</a>, <a class="bk_pop" href="#hps.REF.lowe.2013.766">Lowe et al 2013</a>, <a class="bk_pop" href="#hps.REF.yousaf.2016.231">Yousaf et al 2016</a>, <a class="bk_pop" href="#hps.REF.bryan.2017.378">Bryan et al 2017</a>]. Data are insufficient to determine whether individuals with BLOC-1 deficiency are prone to complications besides albinism and a bleeding diathesis. It appears that these individuals have a silvery/blond/gold hair color at birth that may turn darker with age [<a class="bk_pop" href="#hps.REF.cullinane.2012.584">Cullinane et al 2012</a>, <a class="bk_pop" href="#hps.REF.lowe.2013.766">Lowe et al 2013</a>].</p><p>No pulmonary defects have been reported in these individuals. One Italian individual with <i>BLOC1S6-</i>related HPS presented with immunodeficiency [<a class="bk_pop" href="#hps.REF.badolato.2012.3185">Badolato et al 2012</a>]; therefore, close follow up of other individuals is required to determine if immunodeficiency is a feature of BLOC-1 deficiency.</p></div><div id="hps.HPS3_HPS5_HPS6_BLOC2_Deficiency"><h4><i>HPS3, HPS5, HPS6</i> (BLOC-2 Deficiency)</h4><p>As of July 2017, about 190 individuals with pathogenic variants in <i>HPS3</i>, <i>HPS5</i>, or <i>HPS6</i> have been reported (including ~55 Puerto Rican individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a 3.9-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>HPS3</i> and 20 Israeli-Bedouin individuals homozygous for a frame-shift variant in <i>HPS6</i>). Individuals with pathogenic variants in <i>HPS3</i>, <i>HPS5</i>, or <i>HPS6</i> are BLOC-2 deficient and generally have milder symptoms than those with BLOC-3 deficiency (pathogenic variants in <i>HPS1</i> or <i>HPS4</i>) [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>]. The albinism in individuals with BLOC-2<i>-</i>related HPS can present with such minimal hypopigmentation that some individuals may be diagnosed with ocular albinism rather than oculocutaneous albinism. Visual acuity often approximates 20/100 or better.</p><p>Bleeding is also mild and pulmonary involvement has not been observed in individuals with BLOC-2 deficiency.</p><p>Individuals with BLOC-2 deficiency can go undiagnosed for decades: a new diagnosis of <i>HPS5</i>-related HPS was described in a man age 92 years with light skin and hair, nystagmus, decreasing visual acuity with age, and a bleeding history. He is the oldest reported individual with HPS [<a class="bk_pop" href="#hps.REF.ringeisen.2013.334">Ringeisen et al 2013</a>].</p></div><div id="hps.HPS1_HPS4_BLOC3_Deficiency"><h4><i>HPS1, HPS4</i> (BLOC-3 Deficiency)</h4><p>As of July 2017, approximately 390 individuals with pathogenic variants in <i>HPS1</i> or <i>HPS4</i> have been reported (including ~255 Puerto Rican individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a 16-bp <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in <i>HPS1</i>). These individuals with BLOC-3 deficiency exhibit a generally severe form of oculocutaneous albinism and bleeding diathesis [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>].</p><p>BLOC-3 deficiency is associated with lethal pulmonary fibrosis. The lung fibrosis is a restrictive lung disease and individuals with BLOC-3-deficiency typically begin to display symptoms in their early thirties and progress to death within a decade, unless lung transplantation is achieved [<a class="bk_pop" href="#hps.REF.gahl.2002.234">Gahl et al 2002</a>, <a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>].</p><p>Significant granulomatous colitis occurs primarily in individuals with <i>HPS1</i> or <i>HPS4</i> pathogenic variants [<a class="bk_pop" href="#hps.REF.hussain.2006.73">Hussain et al 2006</a>].</p></div></div><div id="hps.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Correlations between specific HPS-causing variants in any one <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and particular clinical presentations are not convincing.</p></div><div id="hps.Nomenclature"><h3>Nomenclature</h3><p>HPS may have been referred to as non-neuronal ceroid-lipofuscinosis to differentiate it from neuronal ceroid-lipofuscinosis, or Batten disease. In HPS, the nervous system appears to be spared.</p><p>Individuals with HPS with mild hypopigmentation but a bleeding disorder could be referred to as having "delta storage pool deficiency"; however, individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> delta storage pool deficiency do not have vision defects.</p></div><div id="hps.Prevalence"><h3>Prevalence</h3><p>HPS is a rare disorder with an estimated worldwide prevalence of 1-9 per 1,000,000 individuals (<a href="http://www.orpha.net/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.orpha.net</a>).</p><p>The prevalence per subtype can differ due to founder variants. The prevalence of <i>HPS1</i>-related HPS in northwestern Puerto Rico is 1:1800 [<a class="bk_pop" href="#hps.REF.witkop.1989">Witkop et al 1989</a>].</p><p><i>HPS1</i>-related HPS has also been reported in a small isolate in a Swiss village [<a class="bk_pop" href="#hps.REF.schallreuter.1993.248">Schallreuter et al 1993</a>] and as a genetic isolate in Japan [<a class="bk_pop" href="#hps.REF.ito.2005.715">Ito et al 2005</a>].</p><p><i>HPS3</i>-related HPS occurs as a genetic isolate in central Puerto Rico, where about 1:16,000 individuals are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al 2001</a>, <a class="bk_pop" href="#hps.REF.santiago_borrero.2006.85">Santiago Borrero et al 2006</a>]. Newborn screening of 12% of the Puerto Rican population detected two homozygotes and 73 heterozygotes with the common variant <a class="figpopup" href="/books/NBK1287/table/hps.T.hps4_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fighpsThps4pathogenicvariantsdiscussed" rid-ob="figobhpsThps4pathogenicvariantsdiscussed">g.339_4260del3904</a> (also referred to as the 3.9-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) [<a class="bk_pop" href="#hps.REF.torresserrant.2010.448">Torres-Serrant et al 2010</a>].</p><p>Individuals with HPS have been identified in many other regions, including China, India, South America, and Western Europe.</p></div></div><div id="hps.Genetically_Related_Allelic_Disorder"><h2 id="_hps_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be caused by pathogenic variants in <i>AP3B1</i>, <i>AP3D1</i>, <i>BLOC1S3</i>, <i>BLOC1S6</i>, <i>DTNBP1</i>, <i>HPS1</i>, <i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, or <i>HPS6</i>.</p></div><div id="hps.Differential_Diagnosis"><h2 id="_hps_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Albinism.</b> The diagnosis of Hermansky-Pudlak syndrome (HPS) should be considered in anyone with oculocutaneous albinism or ocular albinism, as the bleeding diathesis can be mild, unrecognized, or previously disregarded. Some would advocate screening all individuals with albinism for HPS by examining their platelets for absent dense bodies. The following disorders with albinism are included in the differential diagnosis:</p><ul><li class="half_rhythm"><div><b>Oculocutaneous albinism</b> (OCA) including <a href="/books/n/gene/oca1/">OCA1</a>, <a href="/books/n/gene/oca2/">OCA2</a>, OCA3 (OMIM <a href="https://omim.org/entry/203290" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">203290</a>), <a href="/books/n/gene/oca4/">OCA4</a>, OCA5 (OMIM <a href="https://omim.org/entry/615312" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615312</a>), OCA6 (OMIM <a href="https://omim.org/entry/113750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">113750</a>), and OCA7 (OMIM <a href="https://omim.org/entry/615179" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615179</a>), consists of a group of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders characterized by reduction or complete lack of melanin pigment in the skin, hair, and eyes. Individuals with OCA-related albinism often present with white/blonde/light hair, white or light skin that does not tan and is very susceptible to damage from the sun including skin cancer, and fully translucent irises that do not darken with age. Ocular findings can include nystagmus, reduced iris pigment with iris translucency, reduced retinal pigment, foveal hypoplasia with significantly reduced visual acuity, and misrouting of the optic nerves resulting in alternating strabismus and reduced stereoscopic vision. All individuals with OCA have severe visual changes, but the amount of skin, hair, and iris pigment can vary depending on the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (or type of OCA) and <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involved. The seven types of OCA are caused by pathogenic variants in different genes (<i>TYR, OCA2, TYRP1, SLC45A2, SLC24A5, C10orf11</i>).</div></li><li class="half_rhythm"><div><a href="/books/n/gene/x-oa/"><b>X-linked ocular albinism</b></a>
<b>(XLOA)</b> is caused by pathogenic variants in <i>GPR143</i>. Affected males have minor skin manifestations and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and persistent visual impairment. XLOA is characterized by congenital nystagmus, reduced visual acuity, hypopigmentation of the iris pigment epithelium and the ocular fundus, and foveal hypoplasia. Significant refractive errors, reduced or absent binocular functions, photoaversion, and strabismus are common.</div></li></ul><p><b>Disorders of platelet-dense bodies.</b> Reviewed in <a class="bk_pop" href="#hps.REF.gunayaygun.2004.537">Gunay-Aygun et al [2004]</a>, these disorders include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/chediak-higashi/"><b>Chediak-Higashi syndrome</b></a>
<b>(CHS)</b>, caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LYST</i>. Affected individuals have a significantly increased frequency of infection in childhood, mild oculocutaneous albinism, and a bleeding diathesis. This entity is characterized by huge, fused, dysfunctional lysosomes and macromelanosomes. Individuals with CHS always have giant intracellular granules in their neutrophils on peripheral blood smear; individuals with HPS never exhibit this finding. Persons with CHS also frequently develop fatal lymphohistiocytosis or the accelerated phase of CHS, a finding that also sporadically occurs in <i>AP3B1</i>-related HPS [<a class="bk_pop" href="#hps.REF.enders.2006.81">Enders et al 2006</a>, <a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>]. Without bone marrow transplantation, individuals with classic Chediak-Higashi syndrome die in childhood.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Griscelli syndrome (GS1</b> [OMIM <a href="http://omim.org/entry/214450" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">214450</a>], <b>GS2</b> [OMIM <a href="http://omim.org/entry/607624" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607624</a>], <b>GS3</b> [OMIM <a href="http://omim.org/entry/609227" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609227</a>]<b>)</b>. Affected individuals have mild hypopigmentation and immunodeficiency and can have the accelerated phase of lymphohistiocytosis. A distinguishing finding is silvery-gray hair. GS1, GS2, and GS3 are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</div><div class="half_rhythm">Note: Elejalde syndrome (OMIM <a href="http://omim.org/entry/256710" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">256710</a>) is considered a type of Griscelli syndrome in which neurologic involvement (rather than immunodeficiency and lymphohistiocytosis) occurs.</div></li></ul></div><div id="hps.Management"><h2 id="_hps_Management_">Management</h2><div id="hps.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Hermansky-Pudlak syndrome (HPS), the following are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Complete ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Skin examination for severity of hypopigmentation and, after infancy, for evidence of skin damage and skin cancer</div></li><li class="half_rhythm"><div>History of bleeding problems and symptoms suggesting pulmonary fibrosis and/or colitis. For evaluation for lung fibrosis, pulmonary function tests (PFTs) should be performed in individuals older than age 20 years.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hps.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Eyes</b></p><ul><li class="half_rhythm"><div>The majority of individuals with albinism have significant hyperopia (far-sightedness) or myopia (near-sightedness), and astigmatism. Correction of these refractive errors can improve visual acuity.</div></li><li class="half_rhythm"><div>Strabismus surgery is usually not required but can be performed for cosmetic purposes, particularly if the strabismus is marked or fixed. The surgery is not always successful.</div></li><li class="half_rhythm"><div>Aids such as hand-held magnifying devices or bioptic lenses are helpful adjuncts in the care of visually impaired individuals with HPS.</div></li><li class="half_rhythm"><div>Preferential seating in school is beneficial, and a vision consultant may be useful.</div></li></ul><p><b>Skin.</b> Treatment of skin cancer does not differ from that in the general population.</p><p><b>Bleeding</b></p><ul><li class="half_rhythm"><div>Humidifiers may reduce the frequency of nosebleeds.</div></li><li class="half_rhythm"><div>Oral contraceptives can limit the duration of menstrual periods. Menorrhagia has been treated with a levonorgestrel-releasing intrauterine system [<a class="bk_pop" href="#hps.REF.kingman.2004.1425">Kingman et al 2004</a>] and with recombinant factor VIIa [<a class="bk_pop" href="#hps.REF.lohse.2011.s61">Lohse et al 2011</a>].</div></li><li class="half_rhythm"><div>Treatment of minor cuts includes placing thrombin-soaked Gelfoam<sup>&#x000ae;</sup> over an open wound that fails to clot spontaneously.</div></li><li class="half_rhythm"><div>For more invasive trauma, such as wisdom tooth extraction, DDAVP (1-desamino-8-D-arginine vasopressin, 0.2 &#x000b5;g/kg in 50 mL of normal saline) can be given as a 30-minute intravenous infusion just prior to the procedure. The use of DDAVP may or may not improve the bleeding time [<a class="bk_pop" href="#hps.REF.cordova.2005.51">Cordova et al 2005</a>].</div></li><li class="half_rhythm"><div>For extensive surgeries or protracted bleeding, platelet or red blood cell transfusions may be required.</div></li></ul><p><b>Pulmonary fibrosis</b></p><ul><li class="half_rhythm"><div>When the pulmonary disease becomes severe, oxygen therapy can be palliative.</div></li><li class="half_rhythm"><div>Several individuals with <i>HPS1</i>-related pulmonary fibrosis successfully underwent bilateral or single-lung transplantations [<a class="bk_pop" href="#hps.REF.lederer.2005.1697">Lederer et al 2005</a>]. The authors know of several additional successful lung transplantations.</div></li></ul><p><b>Colitis.</b> The granulomatous colitis of HPS resembles Crohn's colitis and, as such, may respond to steroids and other anti-inflammatory agents [<a class="bk_pop" href="#hps.REF.mora.2011.700">Mora &#x00026; Wolfsohn 2011</a>]. Remicade<sup>&#x000ae;</sup> has also been used with benefit [<a class="bk_pop" href="#hps.REF.erzin.2006.213">Erzin et al 2006</a>, <a class="bk_pop" href="#hps.REF.felipez.2010.665">Felipez et al 2010</a>].</p><p><b>Immunodeficiency.</b> When present, immunodeficiency is typically responsive to granulocyte colony-stimulating factor (G-CSF).</p></div><div id="hps.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p><b>Skin.</b> Skin care in HPS is dictated by the amount of pigment in the skin and the cutaneous response to sunlight. Protection from the sun should be provided to prevent burning, other skin damage, and skin cancer. In very sensitive individuals, sun exposure as short as five to ten minutes can be significant, while exposure of 30 minutes or more is usually significant in less sensitive individuals. Prolonged periods in the sun require skin protection with clothing (hats with brims, long sleeves and pants, and socks). For extremely sun-sensitive individuals, sunscreen with a high SPF value (total blocks with SPF 45-50+) are appropriate; for less sun-sensitive individuals, sunscreen with SPF values of 15 or above can be used.</p><p><b>Bleeding.</b> Individuals with HPS should consider obtaining a medical alert bracelet that explicitly describes the functional platelet defect, as the standard tests for bleeding dysfunction (e.g., platelet count, prothrombin time, partial thromboplastin time) are normal in HPS.</p><p><b>Pulmonary fibrosis.</b> Prior to the development of pulmonary fibrosis, attention should be paid to maximizing pulmonary function. This entails avoidance of cigarette smoke, prompt treatment of pulmonary infections, immunization with influenza and pneumococcal vaccines, and regular moderate exercise.</p></div><div id="hps.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div><b>Eyes.</b> Annual ophthalmologic examination, including assessment of refractive error</div></li><li class="half_rhythm"><div><b>Skin.</b> Annual skin examination for basal cell carcinoma and squamous cell carcinoma, and more frequent examinations for individuals with concerning lesions or a history of skin cancer</div></li><li class="half_rhythm"><div><b>Pulmonary fibrosis.</b> Annual pulmonary function testing in those over age 20 years. A CT examination of the chest with high-resolution images to screen for pulmonary fibrosis is recommended for young adults with pathogenic variants in <i>HPS1, HPS4, and AP3B1</i>.</div></li><li class="half_rhythm"><div><b>Colitis.</b> Colonoscopy to confirm the diagnosis when colitis is suspected (i.e., by presence of a history of cramping, increased mucus in the stool, and rectal bleeding)</div></li></ul></div><div id="hps.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p><b>Bleeding.</b> All aspirin-containing products as well as activities that could involve the risk of a bleeding episode should be avoided.</p><p><b>Pulmonary fibrosis.</b> Cigarette smoking decreases pulmonary function and may worsen progression of pulmonary fibrosis.</p></div><div id="hps.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>In individuals with <i>HPS1-</i> and <i>HPS4</i>-related HPS, the diagnosis will be apparent because the hypopigmentation and nystagmus are clinically evident.</p><p>In rare families with the milder types (<i>HPS3</i>, <i>HPS5</i>, and <i>HPS6</i>-related HPS), the evaluation of apparently unaffected sibs may identify an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and allow identification as early as possible of those who would benefit from prompt initiation of treatment and preventive measures:</p><ul><li class="half_rhythm"><div>If the pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk sibs.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known, platelet whole-mount electron microscopy studies can be used to clarify the genetic status of at-risk sibs.</div></li></ul><p>See <a href="#hps.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hps.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancies should proceed normally for an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother or an affected fetus. Delivery, however, carries risk for bleeding in a woman with HPS; surveillance and a hematology consultation for <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> of bleeding complications during delivery should be initiated once pregnancy is confirmed.</p></div><div id="hps.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Initial studies suggest a salutary effect on pulmonary function of the investigational drug pirfenidone in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with pulmonary function greater than 50% of normal [<a class="bk_pop" href="#hps.REF.gahl.2002.234">Gahl et al 2002</a>]. A follow-up clinical trial was unable to confirm this finding, but also did not refute it [<a class="bk_pop" href="#hps.REF.obrien.2011.128">O'Brien et al 2011</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="hps.Other"><h3>Other</h3><p>In general, opaque contact lenses or darkly tinted lenses do not improve visual function. Dark glasses may be helpful for individuals with albinism, but many prefer to go without dark glasses because they reduce vision.</p><p>No successful therapy for or prophylaxis against the pulmonary fibrosis of HPS exists. Steroids are often tried but have no apparent beneficial effect.</p></div></div><div id="hps.Genetic_Counseling"><h2 id="_hps_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hps.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>All types of Hermansky-Pudlak syndrome (HPS) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="hps.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>AP3B1</i>, <i>AP3D1</i>, <i>BLOC1S3</i>, <i>BLOC1S6, DTNBP1, HPS1</i>, <i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, or <i>HPS6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being neither affected nor a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the chance of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with HPS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Rarely, families with two-generation pseudodominance have been identified; these result from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual having children with a reproductive partner who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the same HPS-associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="hps.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the <i>AP3B1</i>, <i>AP3D1, BLOC1S3</i>, <i>BLOC1S6, DTNBP1</i>, <i>HPS1</i>, <i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, or <i>HPS6</i> pathogenic variants in the family have been identified.</p></div><div id="hps.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#hps.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hps.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="hps.Resources"><h2 id="_hps_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Hermansky-Pudlak Syndrome Network, Inc.</b></div><div>One South Road</div><div>Oyster Bay NY 11771-1905</div><div><b>Phone:</b> 800-789-9HPS</div><div><b>Fax:</b> 516-624-0640</div><div><b>Email:</b> info@hpsnetwork.org</div><div><a href="http://www.hpsnetwork.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hpsnetwork.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Hermansky-Pudlak%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>eyeGENE - National Ophthalmic Disease Genotyping Network Registry</b></div><div><b>Phone:</b> 301-435-3032</div><div><b>Email:</b> eyeGENEinfo@nei.nih.gov</div><div><a href="https://eyegene.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nei.nih.gov/eyegene</a></div></li></ul></div><div id="hps.Molecular_Genetics"><h2 id="_hps_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hps.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hermansky-Pudlak Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8546" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP3B1</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8546" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q14<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00203" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-3 complex subunit beta-1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/adtb3mut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the Adaptin b3a Gene (ADTB3A) (AP3B1)</a><br /><a href="http://databases.lovd.nl/shared/genes/AP3B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3B1 database</a><br /><a href="http://structure.bmc.lu.se/idbase/AP3B1base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3B1base: Mutation registry for Hermansky-Pudlak syndrome 2</a><br /><a href="http://www.ifpcs.org/albinism/hps2mut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Albinism Database Mutations of the b3A subunit of the AP-3 complex gene (AP3B1)</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP3B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3B1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP3B1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3B1</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8943" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP3D1</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8943" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14617" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-3 complex subunit delta-1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP3D1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3D1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP3D1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP3D1</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/388552" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>BLOC1S3</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=388552" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q6QNY0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Biogenesis of lysosome-related organelles complex 1 subunit 3</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/BLOC1S3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S3 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BLOC1S3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S3</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=BLOC1S3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S3</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26258" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>BLOC1S6</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26258" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UL45" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Biogenesis of lysosome-related organelles complex 1 subunit 6</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/BLOC1S6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S6 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BLOC1S6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S6</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=BLOC1S6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BLOC1S6</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84062" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DTNBP1</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84062" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96EV8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dysbindin</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/DTNBP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DTNBP1 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DTNBP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DTNBP1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DTNBP1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DTNBP1</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3257" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPS1</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3257" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q92902" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome 1 protein</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/epmut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the ep-Gene (HPS1)</a><br /><a href="http://www.ifpcs.org/albinism/hps1mut.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Albinism Database Mutations of the Hermansky-Pudlak Syndrome-1 gene (HPS1)</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPS1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS1</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84343" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPS3</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84343" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q24</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q969F9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome 3 protein</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/hps3mut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the HPS3 Gene</a><br /><a href="http://databases.lovd.nl/shared/genes/HPS3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS3 database</a><br /><a href="http://www.ifpcs.org/albinism/hps3mut.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Albinism Database Mutations of the Hermansky-Pudlak Syndrome-3 gene (HPS3)</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPS3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS3</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPS3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS3</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/89781" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPS4</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=89781" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q12<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NQG7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome 4 protein</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/lemut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the Human light ear Gene (le, HPS4)</a><br /><a href="http://databases.lovd.nl/shared/genes/HPS4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS4 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPS4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS4</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPS4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS4</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/11234" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPS5</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=11234" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UPZ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome 5 protein</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/HPS5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS5 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPS5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS5</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPS5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS5</a></td></tr><tr><td headers="hd_b_hps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79803" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPS6</i></a></td><td headers="hd_b_hps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79803" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q24<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q86YV9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hermansky-Pudlak syndrome 6 protein</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/HPS6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS6 database</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPS6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS6</a></td><td headers="hd_b_hps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPS6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPS6</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hps.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hps.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hermansky-Pudlak Syndrome (<a href="/omim/203300,603401,604310,604982,606118,606682,607145,607521,607522,608233,609762,614072,614073,614074,614075,614076,614077,614171,617050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/203300" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">203300</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 1; HPS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603401" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603401</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604310</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 6; BLOC1S6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604982" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604982</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HPS1 GENE; HPS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606118" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606118</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HPS3 GENE; HPS3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606682" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606682</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HPS4 GENE; HPS4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607145" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607145</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607521" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607521</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HPS5 GENE; HPS5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607522" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607522</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HPS6 GENE; HPS6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608233" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608233</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 2; HPS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609762" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609762</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614072" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614072</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 3; HPS3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614073" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614073</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 4; HPS4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614074" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614074</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 5; HPS5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614075</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 6; HPS6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614076" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614076</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 7; HPS7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614077" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614077</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 8; HPS8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614171" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614171</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 9; HPS9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HERMANSKY-PUDLAK SYNDROME 10; HPS10</td></tr></tbody></table></div></div><div id="hps.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The proteins encoded by the ten genes in which pathogenic variants are known to cause HPS associate into four HPS protein complexes, which are involved in intracellular vesicle formation and trafficking [<a class="bk_pop" href="#hps.REF.huizing.2008.359">Huizing et al 2008</a>]. The four complexes:</p><ul><li class="half_rhythm"><div>AP-3, a heterotetrameric complex of which two subunits, encoded by <i>AP3B1</i> and <i>AP3D1</i>, have pathogenic variants causing HPS [<a class="bk_pop" href="#hps.REF.dellangelica.1999.11">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#hps.REF.ammann.2016.997">Ammann et al 2016</a>]</div></li><li class="half_rhythm"><div>BLOC-1 (biogenesis of lysosome-related organelles complex-1), consisting of eight subunits [<a class="bk_pop" href="#hps.REF.falc_np_rez.2002.28191">Falc&#x000f3;n-P&#x000e9;rez et al 2002</a>], three of which have pathogenic variants causing HPS: the protein products of <i>BLOC1S3</i>, <i>BLOC1S6</i>, and <i>DTNBP1</i></div></li><li class="half_rhythm"><div>BLOC-2, including subunits encoded by <i>HPS3,</i>
<i>HPS5</i>, and <i>HPS6</i> [<a class="bk_pop" href="#hps.REF.di_pietro.2004.276">Di Pietro et al 2004</a>]</div></li><li class="half_rhythm"><div>BLOC-3, including subunits encoded by <i>HPS1</i> and <i>HPS4</i> [<a class="bk_pop" href="#hps.REF.martina.2003.29376">Martina et al 2003</a>]</div></li></ul><div id="hps.AP3B1"><h4><i>AP3B1</i></h4><p><b>Gene structure.</b> The longest human <i>AP3B1</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003664" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003664</a>) consists of 27 exons and has an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 3285 bp. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> As of July 2017, an estimated 27 <i>AP3B1</i> pathogenic variants have been identified in about 29 individuals with HPS [<a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>], including a child originally diagnosed with Griscelli syndrome [<a class="bk_pop" href="#hps.REF.enders.2006.81">Enders et al 2006</a>], several individuals originally diagnosed with Chediak-Higashi syndrome [<a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>], and an individual with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pericentric inv(5)(p15.1q14.1) in <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 5, with a breakpoint in <i>AP3B1</i> [<a class="bk_pop" href="#hps.REF.jones.2013.42">Jones et al 2013</a>]. Pathogenic variants in <i>AP3B1</i> are reported in individuals of various ethnic backgrounds, including northern European, Chinese, Lebanese, and Mexican. There are no frequently occurring pathogenic variants in <i>AP3B1</i>, nor any apparent founder variants.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The product of <i>AP3B1</i> is the 1094-amino acid (~121.3-kd) protein AP3B1 (AP-3 &#x003b2;3A), which is a subunit of adaptor complex-3 (AP-3) [<a class="bk_pop" href="#hps.REF.dellangelica.1999.11">Dell'Angelica et al 1999</a>]. The protein has an amino-terminal region (residues 1-642), a hydrophilic span (residues 643-809), and a carboxy-terminal region (810-1094). AP-3 is a heterotetrameric coat protein complex that forms intracellular vesicles (presumably lysosomes and lysosome-related organelles, including melanosomes, dense bodies, and lytic granules) from the trans-Golgi network and endosomes in a clathrin-mediated fashion. AP3B1 interacts with three other AP-3 subunits (&#x003b4;, &#x003bc;, and &#x003c3;) to perform its function [<a class="bk_pop" href="#hps.REF.dellangelica.1999.11">Dell'Angelica et al 1999</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Cellular analysis of some individuals with <i>AP3B1</i>-related HPS demonstrated that pathogenic variants in <i>AP3B1</i> not only reduce expression of the AP3B1 protein, but also of other AP-3 subunits, likely by destabilizing AP-3 complex assembly [<a class="bk_pop" href="#hps.REF.dellangelica.1999.11">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#hps.REF.huizing.2002.150">Huizing et al 2002</a>, <a class="bk_pop" href="#hps.REF.de_boer.2017.1402">de Boer et al 2017</a>]. AP-3 deficiency was shown to decrease internalization of certain integral lysosomal membrane proteins into fibroblasts and default trafficking of selected lysosomal membrane proteins through the plasma membrane [<a class="bk_pop" href="#hps.REF.dellangelica.1999.11">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#hps.REF.huizing.2002.150">Huizing et al 2002</a>], such as the neutrophil granule protein elastase [<a class="bk_pop" href="#hps.REF.di_pietro.2006.4027">Di Pietro et al 2006</a>, <a class="bk_pop" href="#hps.REF.jung.2006.362">Jung et al 2006</a>]. AP-3 deficient cytotoxic T-lymphocytes exhibit enlarged lytic granules that cannot move along microtubules and dock in secretory domains of the immunologic synapse [<a class="bk_pop" href="#hps.REF.clark.2003.1111">Clark et al 2003</a>].</p></div><div id="hps.HPS1"><h4><i>HPS1</i></h4><p><b>Gene structure.</b> The longest <i>HPS1</i> transcript variant (<a href="/nuccore/NM_000195.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000195.3</a>) has 20 exons with a 2103-bp <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> [<a class="bk_pop" href="#hps.REF.bailin.1997.923">Bailin et al 1997</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> As of July 2017, an estimated 102 non-Puerto Rican individuals and 53 distinct pathogenic <i>HPS1</i> variants have been reported. There are also at least 255 (northwest) Puerto Rican individuals reported <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>HPS1</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> c.1470_1486dup16 in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15. Other <i>HPS1</i> pathogenic founder variants are reported in a Swiss Alpine village (c.972dupC) [<a class="bk_pop" href="#hps.REF.schallreuter.1993.248">Schallreuter et al 1993</a>] and in Japanese and Indian individuals (c.398+5G&#x0003e;A) [<a class="bk_pop" href="#hps.REF.ito.2005.715">Ito et al 2005</a>, <a class="bk_pop" href="#hps.REF.vincent.2009.227">Vincent et al 2009</a>]. Otherwise, the most common reported pathogenic variants among non-Puerto Ricans involve the <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of a C nucleotide in a repeat tract of eight Cs that occur in exon 11 (c.972delC and c.972dupC) and exon 13 (c.1189delC).</p><div id="hps.T.hps1_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>HPS1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.hps1_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.hps1_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1)</sup></th><th id="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.398+5G&#x0003e;A<br />(c.644+5G&#x0003e;A)<br />(IVS5+5G&#x0003e;A)</td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000195.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000195<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_000186.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000186<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.972delC<br />(T322delC)</td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met325TrpfsTer6<br />(324ProfsTer330)</td></tr><tr><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1189delC<br />(1395delC)</td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln397SerfsTer2</td></tr><tr><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.972dupC<br />(T322insC)</td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met325HisfsTer128<br />(His325ProfsTer452)</td></tr><tr><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1470_1486dup16</td><td headers="hd_h_hps.T.hps1_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His497ProfsTer24</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="hps.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein product of <i>HPS1</i> is a 700-amino acid protein (~79.3 kd). It has two potential N-linked glycosylation sites (residues 528 and 560) and a possible melanosomal localization signal, PLL, at the carboxy terminus. Although two transmembrane domains (at residues 79-95 and 369-396) have been proposed to exist, the protein is largely cytosolic in location, with a slight portion associating with membranes [<a class="bk_pop" href="#hps.REF.dellangelica.2000.1300">Dell'Angelica et al 2000</a>]. Cellular and biochemical evidence indicates that <i>HPS1</i> gene product interacts with the <i>HPS4</i> gene product in biogenesis of lysosome-related organelles complex-3 (BLOC-3) [<a class="bk_pop" href="#hps.REF.martina.2003.29376">Martina et al 2003</a>]. BLOC-3 was found to interact with Rab9 [<a class="bk_pop" href="#hps.REF.kloer.2010.7794">Kloer et al 2010</a>] and to function as a Rab32/38 guanine nucleotide exchange factor [<a class="bk_pop" href="#hps.REF.gerondopoulos.2012.2135">Gerondopoulos et al 2012</a>]. Recently, it was suggested that BLOC-3 also acts in SNARE protein recycling in the late endosomal system, based on the demonstration that retrieval of the v-SNARE VAMP7 (required for melanogenesis) from melanosomes after cargo delivery requires BLOC-3 [<a class="bk_pop" href="#hps.REF.dennis.2015.563">Dennis et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mutated alleles of <i>HPS1</i> are generally predicted to produce truncated, dysfunctional proteins. Pathogenic variants in one member of BLOC-3 (gene products of <i>HPS1</i> or <i>HPS4</i>) destabilizes the entire complex, causing degradation of the other protein in the complex. By using a specific antibody to the gene product of <i>HPS4</i>, deficiency of <i>HPS1</i> and <i>HPS4</i> gene products can be demonstrated [<a class="bk_pop" href="#hps.REF.nazarian.2008.134">Nazarian et al 2008</a>, <a class="bk_pop" href="#hps.REF.carmonarivera.2011.2394">Carmona-Rivera et al 2011</a>].</p></div><div id="hps.HPS3"><h4><i>HPS3</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> organization of <i>HPS3</i> has been described [<a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al 2001</a>]. Its longest transcript variant (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032383.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032383.3</a>) comprises 17 exons with an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 3015 bp. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> At least 56 (central) Puerto Rican individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a 3.9-kb <i>HPS3</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that removes all of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 and 673 bp of <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1 have been reported [<a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al 2001</a>]. A second <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, c.1163+1G&#x0003e;A, occurs among Ashkenazi Jews [<a class="bk_pop" href="#hps.REF.huizing.2001.1022">Huizing et al 2001</a>].</p><div id="hps.T.hps3_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>HPS3</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.hps3_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.hps3_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.1163+1G&#x0003e;A<br />(1303+1G&#x0003e;A or IVS5+1G&#x0003e;A)</td><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/28416957" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032383<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/19923642" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_115759<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">g.339_4260del3904<br />(3.9-kb del)</td><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hps.T.hps3_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/15088620" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AF375663</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="hps.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>HPS3</i> encodes Hermansky-Pudlak syndrome 3 protein, a 1004-amino acid protein with a predicted molecular weight of 113.7 kd [<a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al 2001</a>]. It is predicted to have no glycosylation sites or transmembrane regions, but to be 43% alpha-helix, 19% extended strand, 30% random coil, and 7% beta-turn. A clathrin binding motif exists at residues 172-176, and binding of the <i>HPS3</i> gene product to clathrin has been demonstrated [<a class="bk_pop" href="#hps.REF.helipwooley.2005.33">Helip-Wooley et al 2005</a>]. The <i>HPS3</i> gene product interacts with the <i>HPS5</i> and <i>HPS6</i> gene products in BLOC-2 [<a class="bk_pop" href="#hps.REF.di_pietro.2004.276">Di Pietro et al 2004</a>]. It was suggested that BLOC-2 facilitates trafficking of lysosome-related organelle components (e.g., TYRP1) from an early/sorting endosomal compartment to the developing lysosome-related organelle [<a class="bk_pop" href="#hps.REF.helipwooley.2007.1471">Helip-Wooley et al 2007</a>, <a class="bk_pop" href="#hps.REF.dennis.2015.563">Dennis et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The central Puerto Rican g.339_4260del3904 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> produces no transcript and no protein [<a class="bk_pop" href="#hps.REF.anikster.2001.376">Anikster et al 2001</a>]. The 1303+1G&#x0003e;A (c.1163+1G&#x0003e;A) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> eliminates <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5, resulting in a premature translational stop at codon 350, which is predicted to produce a truncated protein if <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> escapes the <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay pathway [<a class="bk_pop" href="#hps.REF.huizing.2001.1022">Huizing et al 2001</a>]. The mutated alleles of <i>HPS3</i> are generally predicted to produce truncated, dysfunctional proteins. Cellular studies performed on melanocytes of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with pathogenic <i>HPS3</i> variants indicated abnormal distribution patterns of the melanogenic proteins TYRP1 and TYR, as well as increased trafficking of TYRP1 through the plasma membrane [<a class="bk_pop" href="#hps.REF.boissy.2005.231">Boissy et al 2005</a>, <a class="bk_pop" href="#hps.REF.helipwooley.2007.1471">Helip-Wooley et al 2007</a>].</p><p>Pathogenic variants in one member of BLOC-2 (<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> products of <i>HPS3</i>, <i>HPS5,</i> or <i>HPS6</i>) destabilizes the entire complex, causing degradation of the other proteins in the complex. By using a specific antibody to the gene products of <i>HPS5 or HPS6</i>, deficiency of <i>HPS3, HPS5,</i> and <i>HPS6</i> gene products can be demonstrated in patient's cells [<a class="bk_pop" href="#hps.REF.nazarian.2008.134">Nazarian et al 2008</a>, <a class="bk_pop" href="#hps.REF.carmonarivera.2011.2394">Carmona-Rivera et al 2011</a>].</p></div><div id="hps.HPS4"><h4><i>HPS4</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> organization of <i>HPS4</i> has been described [<a class="bk_pop" href="#hps.REF.anderson.2003.10">Anderson et al 2003</a>]. <i>HPS4</i> has 14 exons covering 32 kb of genomic DNA. Two transcripts of <i>HPS4</i> differ at their 5' ends, with the major, longest transcript (<a href="/nuccore/NM_022081.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022081.5</a>) harboring a 2127-bp <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a>, encoding a 708-amino acid peptide (~76.9 kd) and the minor transcript (<a href="/nuccore/NM_152841.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152841.2</a>) producing a 703-amino acid protein [<a class="bk_pop" href="#hps.REF.anderson.2003.10">Anderson et al 2003</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> The variant c.2089_2093dupAAGCA is frequently occurring in individuals of European descent [<a class="bk_pop" href="#hps.REF.suzuki.2002.321">Suzuki et al 2002</a>, <a class="bk_pop" href="#hps.REF.anderson.2003.10">Anderson et al 2003</a>].</p><div id="hps.T.hps4_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>HPS4</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.hps4_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.hps4_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2089_2093dupAAGCA<br />(c.2093_2094ins or Q698insAAGCA)</td><td headers="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys699SerfsTer5</td><td headers="hd_h_hps.T.hps4_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_022081.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022081<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_071364.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_071364.4</u></a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="hps.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein encoded by <i>HPS4</i> has 708 amino acids with a predicted molecular weight of 76.9 kd [<a class="bk_pop" href="#hps.REF.suzuki.2002.321">Suzuki et al 2002</a>]. The <i>HPS4</i> gene product has been shown to interact with the <i>HPS1</i> gene product in BLOC-3, which is considered to be involved in intracellular vesicle biogenesis [<a class="bk_pop" href="#hps.REF.suzuki.2002.321">Suzuki et al 2002</a>, <a class="bk_pop" href="#hps.REF.martina.2003.29376">Martina et al 2003</a>]. BLOC-3 was found to interact with Rab9 [<a class="bk_pop" href="#hps.REF.kloer.2010.7794">Kloer et al 2010</a>] and to function as a Rab32/38 guanine nucleotide exchange factor [<a class="bk_pop" href="#hps.REF.gerondopoulos.2012.2135">Gerondopoulos et al 2012</a>]. Recently, it was suggested that BLOC-3 also acts in SNARE protein recycling in the late endosomal system, based upon the demonstration that retrieval of the v-SNARE VAMP7 (required for melanogenesis) from melanosomes after cargo delivery requires BLOC-3 [<a class="bk_pop" href="#hps.REF.dennis.2015.563">Dennis et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> No information is available on the abnormal gene products of <i>HPS4</i>. Pathogenic variants in <i>HPS4</i> result in decreased expression of the protein product and cause destabilization of BLOC-3 assembly [<a class="bk_pop" href="#hps.REF.nazarian.2008.134">Nazarian et al 2008</a>, <a class="bk_pop" href="#hps.REF.carmonarivera.2011.2394">Carmona-Rivera et al 2011</a>].</p></div><div id="hps.HPS5"><h4><i>HPS5</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> organization of <i>HPS5</i> has been described [<a class="bk_pop" href="#hps.REF.huizing.2004.711">Huizing et al 2004</a>]. <i>HPS5</i> has 23 exons, spans 43.5 kb of genomic DNA, and has three splice variants, the longest of which (<a href="/nuccore/NM_181507.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_181507.1</a>) is 4.8 kb and contains 23 exons encoding an 1129-amino acid protein. A second splice variant differs in the 5' UTR and lacks the first 114 amino acids coded for by <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2. The third variant resembles variant 2 in lacking the first 114 amino acids, but also lacks a portion of exon 1 [<a class="bk_pop" href="#hps.REF.huizing.2004.711">Huizing et al 2004</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> As of July 2017, an estimated 25 individuals and 27 <i>HPS5</i> pathogenic variants have been reported [<a class="bk_pop" href="#hps.REF.michaud.2017.563">Michaud et al 2017</a>]. There are no apparent frequently occurring pathogenic variants reported in <i>HPS5</i>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>HPS5</i> protein product has 1129 amino acids (127.4 kd) and contains two WD40 domains at low statistical likelihood [<a class="bk_pop" href="#hps.REF.zhang.2003.145">Zhang et al 2003</a>]. It interacts with the products of <i>HPS3</i> and <i>HPS6</i> in BLOC-2 [<a class="bk_pop" href="#hps.REF.di_pietro.2004.276">Di Pietro et al 2004</a>]. <i>HPS5</i> protein product function is not known, but in its absence, LAMP-3-containing fibroblast vesicles cluster around the nucleus and fail to normally populate the cell periphery [<a class="bk_pop" href="#hps.REF.huizing.2004.711">Huizing et al 2004</a>]. It was suggested that BLOC-2 facilitates trafficking of lysosome-related organelle components (e.g., TYRP1) from an early/sorting endosomal compartment to the developing lysosome-related organelle [<a class="bk_pop" href="#hps.REF.helipwooley.2007.1471">Helip-Wooley et al 2007</a>, <a class="bk_pop" href="#hps.REF.dennis.2015.563">Dennis et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mutated alleles of <i>HPS5</i> are generally predicted to produce truncated, dysfunctional proteins. Pathogenic variants in one member of BLOC-2 (gene products of <i>HPS3</i>, <i>HPS5,</i> or <i>HPS6</i>) destabilizes the entire complex, causing degradation of the other protein in the complex. By using a specific antibody to the gene products of <i>HPS5</i> or <i>HPS6</i>, deficiency of <i>HPS3</i>, <i>HPS5</i>, and <i>HPS6</i> gene products can be demonstrated in patients' cells [<a class="bk_pop" href="#hps.REF.nazarian.2008.134">Nazarian et al 2008</a>, <a class="bk_pop" href="#hps.REF.carmonarivera.2011.2394">Carmona-Rivera et al 2011</a>].</p></div><div id="hps.HPS6"><h4><i>HPS6</i></h4><p><b>Gene structure.</b>
<i>HPS6</i> has one <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. Its <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> (<a href="/nuccore/NM_024747.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024747.5</a>) contains a 2328-bp <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> [<a href="/books/NBK1287/#hps.REF.zhang.2003.145" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>Zhang et al 2003</u></a>]. A multiple-tissue northern blot demonstrated that <i>HPS6</i> was expressed in all tissues tested, displaying a transcript size of approximately 2.6 kb, and no alternatively spliced transcripts were present [<a class="bk_pop" href="#hps.REF.huizing.2009.803">Huizing et al 2009</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1287/#hps.molgen.TA">Table A</a>, <b>Gene</b>. Click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf) for gene symbol aliases.</p><p><b>Pathogenic variants.</b> As of July 2017, an estimated 26 individuals and 28 pathogenic <i>HPS3</i> variants have been reported. In addition, another 20 Israeli-Bedouin individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1066_1067insG have been described [<a class="bk_pop" href="#hps.REF.schreyershafir.2006.1158">Schreyer-Shafir et al 2006</a>].</p><div id="hps.T.hps6_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>HPS6</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1287/table/hps.T.hps6_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hps.T.hps6_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DNA Nucleotide Change</th><th id="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1066_1067insG</td><td headers="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu356ArgfsTer11</td><td headers="hd_h_hps.T.hps6_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/nuccore/31881784" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024747<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/31881785" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_079023<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The human <i>HPS6</i> <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> is predicted to code for a 775-amino acid, 83-kd protein of unknown function. The protein is highly homologous to its mammalian orthologs, but lacks homology to any other protein. No functional domains, leader sequence, or N-glycosylation sites are predicted [<a class="bk_pop" href="#hps.REF.zhang.2003.145">Zhang et al 2003</a>, <a class="bk_pop" href="#hps.REF.huizing.2009.803">Huizing et al 2009</a>]. The <i>HPS6</i> gene product interacts with the <i>HPS3</i> and <i>HPS5</i> products in BLOC-2 [<a class="bk_pop" href="#hps.REF.di_pietro.2004.276">Di Pietro et al 2004</a>]. It was suggested that BLOC-2 facilitates trafficking of lysosome-related organelle components (e.g., TYRP1) from an early/sorting endosomal compartment to the developing lysosome-related organelle [<a class="bk_pop" href="#hps.REF.helipwooley.2007.1471">Helip-Wooley et al 2007</a>, <a class="bk_pop" href="#hps.REF.dennis.2015.563">Dennis et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Cellular studies performed on melanocytes of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with aberrant <i>HPS6</i> gene product expression indicated abnormal distribution patterns of the melanogenic proteins TYRP1 and TYR, as well as increased trafficking of TYRP1 through the plasma membrane [<a class="bk_pop" href="#hps.REF.huizing.2009.803">Huizing et al 2009</a>], similar to those described for other BLOC-2 melanocytes [<a class="bk_pop" href="#hps.REF.boissy.2005.231">Boissy et al 2005</a>, <a class="bk_pop" href="#hps.REF.helipwooley.2007.1471">Helip-Wooley et al 2007</a>]. These findings confirmed that the BLOC-2 subunits act in the same pathway of lysosome-related organelles biogenesis. Pathogenic variants in one member of BLOC-2 (gene products of <i>HPS3</i>, <i>HPS5</i>, or <i>HPS6</i>) destabilizes the entire complex, causing degradation of the other protein in the complex. By using a specific antibody to the gene products of <i>HPS5</i> or <i>HPS6</i>, deficiency of <i>HPS3</i>, <i>HPS5</i>, and <i>HPS6</i> gene products can be demonstrated in the cells of affected individuals [<a class="bk_pop" href="#hps.REF.nazarian.2008.134">Nazarian et al 2008</a>, <a class="bk_pop" href="#hps.REF.carmonarivera.2011.2394">Carmona-Rivera et al 2011</a>].</p><p>For information about genes in <a class="figpopup" href="/books/NBK1287/table/hps.T.molecular_genetics_of_hermanskypud_1/?report=objectonly" target="object" rid-figpopup="fighpsTmoleculargeneticsofhermanskypud1" rid-ob="figobhpsTmoleculargeneticsofhermanskypud1">Table 1b</a> click <a href="/books/NBK1287/bin/hps-molgen_suppl.pdf">here</a> (pdf).</p></div></div></div><div id="hps.References"><h2 id="_hps_References_">References</h2><div id="hps.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hps.REF.ammann.2016.997">Ammann S, Schulz A, Krageloh-Mann I, Dieckmann NM, Niethammer K, Fuchs S, Eckl KM, Plank R, Werner R, Altmuller J, Thiele H, Nurnberg P, Bank J, Strauss A, von Bernuth H, Zur Stadt U, Grieve S, Griffiths GM, Lehmberg K, Hennies HC, Ehl S. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. <span><span class="ref-journal">Blood. </span>2016;<span class="ref-vol">127</span>:997–1006.</span> [<a href="/pubmed/26744459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26744459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.anderson.2003.10">Anderson PD, Huizing M, Claassen DA, White J, Gahl WA. Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. <span><span class="ref-journal">Hum Genet. </span>2003;<span class="ref-vol">113</span>:10–7.</span> [<a href="/pubmed/12664304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12664304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.anikster.2001.376">Anikster Y, Huizing M, White J, Shevchenko YO, Fitzpatrick DL, Touchman JW, Compton JG, Bale SJ, Swank RT, Gahl WA, Toro JR. Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:376–80.</span> [<a href="/pubmed/11455388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11455388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.avila.2002.887">Avila NA, Brantly M, Premkumar A, Huizing M, Dwyer A, Gahl WA. Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2002;<span class="ref-vol">179</span>:887–92.</span> [<a href="/pubmed/12239031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12239031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.badolato.2012.3185">Badolato R, Prandini A, Caracciolo S, Colombo F, Tabellini G, Giacomelli M, Cantarini ME, Pession A, Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Saunders CJ, Zhang L, Schroth GP, Plebani A, Parolini S, Kingsmore SF. Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome. <span><span class="ref-journal">Blood. </span>2012;<span class="ref-vol">119</span>:3185–7.</span> [<a href="/pubmed/22461475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22461475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.bailin.1997.923">Bailin T, Oh J, Feng GH, Fukai K, Spritz RA. Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene. <span><span class="ref-journal">J Invest Dermatol. </span>1997;<span class="ref-vol">108</span>:923–7.</span> [<a href="/pubmed/9182823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9182823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.boissy.2005.231">Boissy RE, Richmond B, Huizing M, Helip-Wooley A, Zhao Y, Koshoffer A, Gahl WA. Melanocyte-specific proteins are aberrantly trafficked in melanocytes of Hermansky-Pudlak syndrome-type 3. <span><span class="ref-journal">Am J Pathol. </span>2005;<span class="ref-vol">166</span>:231–40.</span> [<a href="/pmc/articles/PMC1602298/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1602298</span></a>] [<a href="/pubmed/15632015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15632015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.brantly.2000.129">Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. <span><span class="ref-journal">Chest. </span>2000;<span class="ref-vol">117</span>:129–36.</span> [<a href="/pubmed/10631210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10631210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.bryan.2017.378">Bryan MM, Tolman NJ, Simon KL, Huizing M, Hufnagel RB, Brooks BP, Speransky V, Mullikin JC, Gahl WA, Malicdan MC, Gochuico BR. Clinical and molecular phenotyping of a child with Hermansky-Pudlak syndrome-7, an uncommon genetic type of HPS. <span><span class="ref-journal">Mol Genet Metab. </span>2017;<span class="ref-vol">120</span>:378–83.</span> [<a href="/pmc/articles/PMC5395203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5395203</span></a>] [<a href="/pubmed/28259707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28259707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.carmonarivera.2011.2394">Carmona-Rivera C, Golas G, Hess RA, Cardillo ND, Martin EH, O'Brien K, Tsilou E, Gochuico BR, White JG, Huizing M, Gahl WA. Clinical, molecular, and cellular features of non-Puerto Rican Hermansky-Pudlak syndrome patients of Hispanic descent. <span><span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:2394–400.</span> [<a href="/pmc/articles/PMC3213276/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213276</span></a>] [<a href="/pubmed/21833017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21833017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.clark.2003.1111">Clark RH, Stinchcombe JC, Day A, Blott E, Booth S, Bossi G, Hamblin T, Davies EG, Griffiths GM. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. <span><span class="ref-journal">Nat Immunol. </span>2003;<span class="ref-vol">4</span>:1111–20.</span> [<a href="/pubmed/14566336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14566336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.cordova.2005.51">Cordova A, Barrios NJ, Ortiz I, Rivera E, Cadilla C, Santiago-Borrero PJ. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2005;<span class="ref-vol">44</span>:51–4.</span> [<a href="/pubmed/15368543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15368543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.cullinane.2012.584">Cullinane AR, Curry JA, Golas G, Pan J, Carmona-Rivera C, Hess RA, White JG, Huizing M, Gahl WA. A BLOC-1 mutation screen reveals a novel BLOC1S3 mutation in Hermansky-Pudlak Syndrome type 8 (HPS-8). <span><span class="ref-journal">Pigment Cell Melanoma Res. </span>2012;<span class="ref-vol">25</span>:584–91.</span> [<a href="/pmc/articles/PMC3501949/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3501949</span></a>] [<a href="/pubmed/22709368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22709368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.de_boer.2017.1402">de Boer M, van Leeuwen K, Geissler J, van Alphen F, de Vries E, van der Kuip M, Terheggen SWJ, Janssen H, van den Berg TK, Meijer AB, Roos D, Kuijpers TW. Hermansky-Pudlak syndrome type 2: Aberrant pre-mRNA splicing and mislocalization of granule proteins in neutrophils. <span><span class="ref-journal">Hum Mutat. </span>2017;<span class="ref-vol">38</span>:1402–11.</span> [<a href="/pubmed/28585318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28585318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.dellangelica.2000.1300">Dell'Angelica EC, Aguilar RC, Wolins N, Hazelwood S, Gahl WA, Bonifacino JS. Molecular characterization of the protein encoded by the Hermansky- Pudlak syndrome type 1 gene. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:1300–6.</span> [<a href="/pubmed/10625677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10625677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.dellangelica.1999.11">Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. <span><span class="ref-journal">Mol Cell. </span>1999;<span class="ref-vol">3</span>:11–21.</span> [<a href="/pubmed/10024875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10024875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.dennis.2015.563">Dennis MK, Mantegazza AR, Snir OL, Tenza D, Acosta-Ruiz A, Delevoye C, Zorger R, Sitaram A, de Jesus-Rojas W, Ravichandran K, Rux J, Sviderskaya EV, Bennett DC, Raposo G, Marks MS, Setty SR. BLOC-2 targets recycling endosomal tubules to melanosomes for cargo delivery. <span><span class="ref-journal">J Cell Biol. </span>2015;<span class="ref-vol">209</span>:563–77.</span> [<a href="/pmc/articles/PMC4442807/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4442807</span></a>] [<a href="/pubmed/26008744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26008744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.di_pietro.2004.276">Di Pietro SM, Falc&#x000f3;n-P&#x000e9;rez JM, Dell'Angelica EC. Characterization of BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3, HPS5 and HPS6. <span><span class="ref-journal">Traffic. </span>2004;<span class="ref-vol">5</span>:276–83.</span> [<a href="/pubmed/15030569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15030569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.di_pietro.2006.4027">Di Pietro SM, Falc&#x000f3;n-P&#x000e9;rez JM, Tenza D, Setty SR, Marks MS, Raposo G, Dell'Angelica GE. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. <span><span class="ref-journal">Mol Biol Cell. </span>2006;<span class="ref-vol">17</span>:4027–38.</span> [<a href="/pmc/articles/PMC1593172/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1593172</span></a>] [<a href="/pubmed/16837549" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16837549</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.enders.2006.81">Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM, Kontny U, Muller C, Nurden A, Rohr J, Henschen M, Pannicke U, Niemeyer C, Nurden P, Ehl S. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:81–7.</span> [<a href="/pubmed/16551969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16551969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.erzin.2006.213">Erzin Y, Cosgun S, Dobrucali A, Tasyurekli M, Erdamar S, Tuncer M. Complicated granulomatous colitis in a patient with Hermansky-Pudlak syndrome, successfully treated with infliximab. <span><span class="ref-journal">Acta Gastroenterol Belg. </span>2006;<span class="ref-vol">69</span>:213–6.</span> [<a href="/pubmed/16929618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16929618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.falc_np_rez.2002.28191">Falc&#x000f3;n-P&#x000e9;rez JM, Starcevic M, Gautam R, Dell'Angelica EC. BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet-dense granules. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:28191–9.</span> [<a href="/pubmed/12019270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12019270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.felipez.2010.665">Felipez LM, Gokhale R, Guandalini S. Hermansky-Pudlak syndrome: severe colitis and good response to infliximab. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2010;<span class="ref-vol">51</span>:665–7.</span> [<a href="/pubmed/20543722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20543722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.fontana.2006.4857">Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M, Benassi M, Gentili F, Ferrari D, Notarangelo LD, Cavadini P, Marcenaro E, Dusi S, Cassatella M, Facchetti F, Griffiths GM, Moretta A, Notarangelo LD, Badolato R. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4857–64.</span> [<a href="/pubmed/16507770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16507770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gahl.1998.1258">Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, Duffy LF, Kuehl EM, Troendle J, Bernardini I. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">338</span>:1258–64.</span> [<a href="/pubmed/9562579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9562579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gahl.2002.234">Gahl WA, Brantly M, Troendle J, Avila NA, Padua A, Montalvo C, Cardona H, Calis KA, Gochuico B. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">76</span>:234–42.</span> [<a href="/pubmed/12126938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12126938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gerondopoulos.2012.2135">Gerondopoulos A, Langemeyer L, Liang JR, Linford A, Barr FA. BLOC-3 mutated in Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide exchange factor. <span><span class="ref-journal">Curr Biol. </span>2012;<span class="ref-vol">22</span>:2135–9.</span> [<a href="/pmc/articles/PMC3502862/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3502862</span></a>] [<a href="/pubmed/23084991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23084991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gochuico.2012.56">Gochuico BR, Huizing M, Golas GA, Scher CD, Tsokos M, Denver SD, Frei-Jones MJ, Gahl WA. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease. <span><span class="ref-journal">Mol Med. </span>2012;<span class="ref-vol">18</span>:56–64.</span> [<a href="/pmc/articles/PMC3269640/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3269640</span></a>] [<a href="/pubmed/22009278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22009278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gradstein.2005.369">Gradstein L, FitzGibbon EJ, Tsilou ET, Rubin BI, Huizing M, Gahl WA. Eye movement abnormalities in hermansky-pudlak syndrome. <span><span class="ref-journal">J AAPOS. </span>2005;<span class="ref-vol">9</span>:369–78.</span> [<a href="/pubmed/16102489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16102489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.griffin.2005.23">Griffin AE, Cobb BR, Anderson PD, Claassen DA, Helip-Wooley A, Huizing M, Gahl WA. Detection of hemizygosity in Hermansky-Pudlak syndrome by quantitative real-time PCR. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:23–30.</span> [<a href="/pubmed/15952982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15952982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.gunayaygun.2004.537">Gunay-Aygun M, Huizing M, Gahl WA. Molecular defects that affect platelet dense granules. <span><span class="ref-journal">Semin Thromb Hemost. </span>2004;<span class="ref-vol">30</span>:537–47.</span> [<a href="/pubmed/15497096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15497096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.helipwooley.2007.1471">Helip-Wooley A, Westbroek W, Dorward HM, Koshoffer A, Huizing M, Boissy RE, Gahl WA. Improper trafficking of melanocyte-specific proteins in Hermansky-Pudlak syndrome type-5. <span><span class="ref-journal">J Invest Dermatol. </span>2007;<span class="ref-vol">127</span>:1471–8.</span> [<a href="/pubmed/17301833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17301833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.helipwooley.2005.33">Helip-Wooley A, Westbroek W, Dorward H, Mommaas M, Boissy RE, Gahl WA, Huizing M. Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin. <span><span class="ref-journal">BMC Cell Biol. </span>2005;<span class="ref-vol">6</span>:33.</span> [<a href="/pmc/articles/PMC1249560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1249560</span></a>] [<a href="/pubmed/16159387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16159387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2001.1022">Huizing M, Anikster Y, Fitzpatrick DL, Jeong AB, D'Souza M, Rausche M, Toro JR, Kaiser-Kupfer MI, White JG, Gahl WA. Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:1022–32.</span> [<a href="/pmc/articles/PMC1274349/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274349</span></a>] [<a href="/pubmed/11590544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11590544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2008.359">Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. <span><span class="ref-journal">Annu Rev Genomics Hum Genet. </span>2008;<span class="ref-vol">9</span>:359–86.</span> [<a href="/pmc/articles/PMC2755194/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2755194</span></a>] [<a href="/pubmed/18544035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18544035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2004.711">Huizing M, Hess R, Dorward H, Claassen DA, Helip-Wooley A, Kleta R, Kaiser-Kupfer MI, White JG, Gahl WA. Cellular, molecular and clinical characterization of patients with Hermansky-Pudlak syndrome type 5. <span><span class="ref-journal">Traffic. </span>2004;<span class="ref-vol">5</span>:711–22.</span> [<a href="/pubmed/15296495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15296495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2007.150">Huizing M, Parkes JM, Helip-Wooley A, White JG, Gahl WA. Platelet alpha granules in BLOC-2 and BLOC-3 subtypes of Hermansky-Pudlak syndrome. <span><span class="ref-journal">Platelets. </span>2007;<span class="ref-vol">18</span>:150–7.</span> [<a href="/pubmed/17365864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17365864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2009.803">Huizing M, Pederson B, Hess RA, Griffin A, Helip-Wooley A, Westbroek W, Dorward H, O'Brien KJ, Golas G, Tsilou E, White JG, Gahl WA. Clinical and cellular characterization of Hermansky-Pudlak syndrome type-6. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:803–10.</span> [<a href="/pmc/articles/PMC3500784/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3500784</span></a>] [<a href="/pubmed/19843503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19843503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.huizing.2002.150">Huizing M, Scher CD, Strovel E, Fitzpatrick DL, Hartnell LM, Anikster Y, Gahl WA. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. <span><span class="ref-journal">Pediatr Res. </span>2002;<span class="ref-vol">51</span>:150–8.</span> [<a href="/pubmed/11809908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11809908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.hussain.2006.73">Hussain N, Quezado M, Huizing M, Geho D, White JG, Gahl W, Mannon P. Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:73–80.</span> [<a href="/pubmed/16431308" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16431308</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.ito.2005.715">Ito S, Suzuki T, Inagaki K, Suzuki N, Takamori K, Yamada T, Nakazawa M, Hatano M, Takiwaki H, Kakuta Y, Spritz RA, Tomita Y. High frequency of Hermansky-Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein. <span><span class="ref-journal">J Invest Dermatol. </span>2005;<span class="ref-vol">125</span>:715–20.</span> [<a href="/pubmed/16185271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16185271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.iwata.2000.783">Iwata F, Reed GF, Caruso RC, Kuehl EM, Gahl WA, Kaiser-Kupfer MI. Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism. <span><span class="ref-journal">Ophthalmology. </span>2000;<span class="ref-vol">107</span>:783–9.</span> [<a href="/pubmed/10768343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10768343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.jessen.2013.2943">Jessen B, Bode SF, Ammann S, Chakravorty S, Davies G, Diestelhorst J, Frei-Jones M, Gahl WA, Gochuico BR, Griese M, Griffiths G, Janka G, Klein C, K&#x000f6;gl T, Kurnik K, Lehmberg K, Maul-Pavicic A, Mumford AD, Pace D, Parvaneh N, Rezaei N, de Saint Basile G, Schmitt-Graeff A, Schwarz K, Karasu GT, Zieger B, Zur Stadt U, Aichele P, Ehl S. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>:2943–51.</span> [<a href="/pmc/articles/PMC3624940/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3624940</span></a>] [<a href="/pubmed/23403622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23403622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.jones.2013.42">Jones ML, Murden SL, Brooks C, Maloney V, Manning RA, Gilmour KC, Bharadwaj V, de la Fuente J, Chakravorty S, Mumford AD. Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2. <span><span class="ref-journal">BMC Med Genet. </span>2013;<span class="ref-vol">14</span>:42.</span> [<a href="/pmc/articles/PMC3663694/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3663694</span></a>] [<a href="/pubmed/23557002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23557002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.jung.2006.362">Jung J, Bohn G, Allroth A, Boztug K, Brandes G, Sandrock I, Schaffer AA, Rathinam C, Kollner I, Beger C, Schilke R, Welte K, Grimbacher B, Klein C. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:362–9.</span> [<a href="/pmc/articles/PMC1895843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1895843</span></a>] [<a href="/pubmed/16537806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16537806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.king.2001">King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. Vol 4. New York, NY: McGraw-Hill; 2001:5587-627.</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.kingman.2004.1425">Kingman CE, Kadir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. <span><span class="ref-journal">BJOG. </span>2004;<span class="ref-vol">111</span>:1425–8.</span> [<a href="/pubmed/15663130" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15663130</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.kloer.2010.7794">Kloer DP, Rojas R, Ivan V, Moriyama K, van Vlijmen T, Murthy N, Ghirlando R, van der Sluijs P, Hurley JH, Bonifacino JS. Assembly of the biogenesis of lysosome-related organelles complex-3 (BLOC-3) and its interaction with Rab9. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>:7794–804.</span> [<a href="/pmc/articles/PMC2844223/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2844223</span></a>] [<a href="/pubmed/20048159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20048159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.lederer.2005.1697">Lederer DJ, Kawut SM, Sonett JR, Vakiani E, Seward SL Jr, White JG, Wilt JS, Marboe CC, Gahl WA, Arcasoy SM. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. <span><span class="ref-journal">J Heart Lung Transplant. </span>2005;<span class="ref-vol">24</span>:1697–9.</span> [<a href="/pubmed/16210149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16210149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.li.2003.84">Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, Tinsley CL, Blake DJ, Spritz RA, Copeland NG, Jenkins NA, Amato D, Roe BA, Starcevic M, Dell'Angelica EC, Elliott RW, Mishra V, Kingsmore SF, Paylor RE, Swank RT. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">35</span>:84–9.</span> [<a href="/pmc/articles/PMC2860733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2860733</span></a>] [<a href="/pubmed/12923531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12923531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.lohse.2011.s61">Lohse J, Gehrisch S, Tauer JT, Kn&#x000f6;fler R. Therapy refractory menorrhagia as first manifestation of Hermansky-Pudlak syndrome. <span><span class="ref-journal">Hamostaseologie. </span>2011;<span class="ref-vol">31</span> Suppl 1:S61–3.</span> [<a href="/pubmed/22057877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22057877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.lowe.2013.766">Lowe GC, S&#x000e1;nchez Guiu I, Chapman O, Rivera J, Lordkipanidz&#x000e9; M, Dovlatova N, Wilde J, Watson SP, Morgan NV., UK GAPP collaborative.  Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life. <span><span class="ref-journal">Thromb Haemost. </span>2013;<span class="ref-vol">109</span>:766–8.</span> [<a href="/pmc/articles/PMC3641626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3641626</span></a>] [<a href="/pubmed/23364359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23364359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.martina.2003.29376">Martina JA, Moriyama K, Bonifacino JS. BLOC-3, a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:29376–84.</span> [<a href="/pubmed/12756248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12756248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.michaud.2017.563">Michaud V, Lasseaux E, Plaisant C, Verloes A, Perdomo-Trujillo Y, Hamel C, Elcioglu NH, Leroy B, Kaplan J, Jouk PS, Lacombe D, Fergelot P, Morice-Picard F, Arveiler B. Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS. <span><span class="ref-journal">Pigment Cell Melanoma Res. </span>2017;<span class="ref-vol">30</span>:563–70.</span> [<a href="/pubmed/28640947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28640947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.mora.2011.700">Mora AJ, Wolfsohn DM. The management of gastrointestinal disease in Hermansky-Pudlak syndrome. <span><span class="ref-journal">J Clin Gastroenterol. </span>2011;<span class="ref-vol">45</span>:700–2.</span> [<a href="/pubmed/21085008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21085008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.morgan.2006.160">Morgan NV, Pasha S, Johnson CA, Ainsworth JR, Eady RA, Dawood B, McKeown C, Trembath RC, Wilde J, Watson SP, Maher ER. A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:160–6.</span> [<a href="/pmc/articles/PMC1380215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1380215</span></a>] [<a href="/pubmed/16385460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16385460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.nazarian.2008.134">Nazarian R, Huizing M, Helip-Wooley A, Starcevic M, Gahl WA, Dell-Angelica EC. An immunoblotting assay to facilitate the molecular diagnosis of Hermansky-Pudlak syndrome. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">93</span>:134–44.</span> [<a href="/pmc/articles/PMC2242292/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2242292</span></a>] [<a href="/pubmed/17933573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17933573</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.obrien.2011.128">O'Brien K, Troendle J, Gochuico BR, Markello TC, Salas J, Cardona H, Yao J, Bernardini I, Hess R, Gahl WA. Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">103</span>:128–34.</span> [<a href="/pmc/articles/PMC3656407/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3656407</span></a>] [<a href="/pubmed/21420888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21420888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.ringeisen.2013.334">Ringeisen AL, Schimmenti LA, White JG, Schoonveld C, Summers CG. Hermansky-Pudlak syndrome (HPS5) in a nonagenarian. <span><span class="ref-journal">J AAPOS. </span>2013;<span class="ref-vol">17</span>:334–6.</span> [<a href="/pubmed/23607980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23607980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.santiago_borrero.2006.85">Santiago Borrero PJ, Rodriguez-Perez Y, Renta JY, Izquierdo NJ, Del Fierro L, Munoz D, Molina NL, Ramirez S, Pagan-Mercado G, Ortiz I, Rivera-Caragol E, Spritz RA, Cadilla CL. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. <span><span class="ref-journal">J Invest Dermatol. </span>2006;<span class="ref-vol">126</span>:85–90.</span> [<a href="/pmc/articles/PMC3560388/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3560388</span></a>] [<a href="/pubmed/16417222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16417222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.schallreuter.1993.248">Schallreuter KU, Frenk E, Wolfe LS, Witkop CJ, Wood JM. Hermansky-Pudlak syndrome in a Swiss population. <span><span class="ref-journal">Dermatology. </span>1993;<span class="ref-vol">187</span>:248–56.</span> [<a href="/pubmed/8274781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8274781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.schreyershafir.2006.1158">Schreyer-Shafir N, Huizing M, Anikster Y, Nusinker Z, Bejarano-Achache I, Maftzir G, Resnik L, Helip-Wooley A, Westbroek W, Gradstein L, Rosenmann A, Blumenfeld A. A new genetic isolate with a unique phenotype of syndromic oculocutaneous albinism: clinical, molecular, and cellular characteristics. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:1158.</span> [<a href="/pubmed/17041891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17041891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.suzuki.2002.321">Suzuki T, Wei L, Zhang Q, Karim A, Novak EK, Sviderskaya EV, Hill SP, Bennett DC, Levin AV, Nieuwenhuis HK, Fong C-T, Castellan C, Miterski B, Swank RT, Spritz RA. Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">30</span>:321–4.</span> [<a href="/pubmed/11836498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11836498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.toro.1999.774">Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. <span><span class="ref-journal">Arch Dermatol. </span>1999;<span class="ref-vol">135</span>:774–80.</span> [<a href="/pubmed/10411151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10411151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.torresserrant.2010.448">Torres-Serrant M, Ramirez SI, Cadilla CL, Ramos-Valencia G, Santiago-Borrero PJ. Newborn screening for Hermansky-Pudlak syndrome type 3 in Puerto Rico. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2010;<span class="ref-vol">32</span>:448–53.</span> [<a href="/pmc/articles/PMC3640623/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3640623</span></a>] [<a href="/pubmed/20562649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20562649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.vincent.2009.227">Vincent LM, Adams D, Hess RA, Ziegler SG, Tsilou E, Golas G, O'Brien KJ, White JG, Huizing M, Gahl WA. Hermansky-Pudlak syndrome type 1 in patients of Indian descent. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">97</span>:227–33.</span> [<a href="/pmc/articles/PMC2694228/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2694228</span></a>] [<a href="/pubmed/19398212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19398212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.wei.2016.702">Wei A, Yuan Y, Bai D, Ma J, Hao Z, Zhang Y, Yu J, Zhou Z, Yang L, Yang X, Li L, Li W. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients. <span><span class="ref-journal">Pigment Cell Melanoma Res. </span>2016;<span class="ref-vol">29</span>:702–6.</span> [<a href="/pubmed/27593200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27593200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.wenham.2010.333">Wenham M, Grieve S, Cummins M, Jones ML, Booth S, Kilner R, Ancliff PJ, Griffiths GM, Mumford AD. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>:333–7.</span> [<a href="/pmc/articles/PMC2817039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2817039</span></a>] [<a href="/pubmed/19679886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19679886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.witkop.1989">Witkop CJ, Quevedo WC, Fitzpatrick TB, King RA. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. <em>The Metabolic and Molecular Basis of Inherited Disease</em>. 6 ed. Vol 2. New York, NY: McGraw-Hill; 1989:2905-47.</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.yousaf.2016.231">Yousaf S, Shahzad M, Kausar T, Sheikh SA, Tariq N, Shabbir AS, Ali M, Waryah AM, Shaikh RS, Riazuddin S, Ahmed ZM, et al.  Identification and clinical characterization of Hermansky-Pudlak syndrome alleles in the Pakistani population. <span><span class="ref-journal">Pigment Cell Melanoma Res. </span>2016;<span class="ref-vol">29</span>:231–5.</span> [<a href="/pmc/articles/PMC5062593/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5062593</span></a>] [<a href="/pubmed/26575419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26575419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hps.REF.zhang.2003.145">Zhang Q, Zhao B, Li W, Oiso N, Novak EK, Rusiniak ME, Gautam R, Chintala S, O'Brien EP, Zhang Y, Roe BA, Elliott RW, Eicher EM, Liang P, Kratz C, Legius E, Spritz RA, O'Sullivan TN, Copeland NG, Jenkins NA, Swank RT. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:145–53.</span> [<a href="/pubmed/12548288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12548288</span></a>]</div></li></ul></div></div><div id="hps.Chapter_Notes"><h2 id="_hps_Chapter_Notes_">Chapter Notes</h2><div id="hps.Author_Notes"><h3>Author Notes</h3><p>Dr Huizing, PhD, is a cell biologist and geneticist who performs basic research on HPS and related disorders. She genetically subtyped over 250 patients with HPS, studied their cells for the underlying cellular defects, and published extensively on the disease.</p><p>Dr Malicdan, MD, PhD, is a cell biologist and geneticist who performs basic and translational research on HPS and related disorders.</p><p>Dr Gochuico, MD, is a pulmonologist who initiated and developed a translational program to study subpopulations of pulmonary fibrosis. She is performing clinical research on the pulmonary fibrosis of HPS. Her publications on the subject contributed to the understanding of pathogenic mechanisms of subclinical and symptomatic pulmonary fibrosis.</p><p>Dr Gahl, MD PhD, is a pediatrician, medical geneticist, and biochemical geneticist who performs clinical and basic research into rare diseases. He has seen more than 350 patients with HPS and published more than 75 original articles and reviews on the subject in the past nine years.</p></div><div id="hps.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.</p></div><div id="hps.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 October 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 December 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 February 2013 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available for <i>AP3B1</i>, <i>HPS3</i>, <i>HPS6</i>, and <i>BLOC1S6</i>; <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available for <i>BLOC1S6</i></div></li><li class="half_rhythm"><div>11 October 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 July 2010 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for mutations in <i>AP3B1</i> (<i>HPS2</i>), <i>HPS5</i>, <i>HPS6</i>, and <i>BLOC1S3</i> (<i>HPS8</i>)</div></li><li class="half_rhythm"><div>4 May 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 November 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for <i>HPS1</i> and <i>HPS4</i>; <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available for <i>HPS4</i>.</div></li><li class="half_rhythm"><div>21 March 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 December 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 January 2003 (tk) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 July 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>27 January 2000 (wg) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Hermansky-Pudlak Syndrome" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1287</span><span class="label">PMID: <a href="/pubmed/20301464" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301464</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/taa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tay-sachs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1287&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1287/?report=reader">PubReader</a></li><li><a href="/books/NBK1287/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1287" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1287" style="display:none" title="Cite this Page"><div class="bk_tt">Huizing M, Malicdan MCV, Gochuico BR, et al. Hermansky-Pudlak Syndrome. 2000 Jul 24 [Updated 2017 Oct 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1287/pdf/Bookshelf_NBK1287.pdf">PDF version of this page</a> (305K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hps.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hps.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hps.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hps.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hps.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hps.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hps.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hps.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hps.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hps.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hps.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79803[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPS6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84343[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPS3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3257[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11234[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPS5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=89781[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPS4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84062[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DTNBP1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8546[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP3B1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8943[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP3D1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26258[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BLOC1S6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=388552[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BLOC1S3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1287+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1496220" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1496220" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1496220" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1496220" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31619213" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.</a><span class="source">[BMC Pulm Med. 2019]</span><div class="brieflinkpop offscreen_noflow">Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Doubková M, Trizuljak J, Vrzalová Z, Hrazdirová A, Blaháková I, Radová L, Pospíšilová Š, Doubek M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Pulm Med. 2019 Oct 16; 19(1):178. Epub 2019 Oct 16.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301683" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hayashi M, Suzuki T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301345" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lewis RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28640947" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.</a><span class="source">[Pigment Cell Melanoma Res. 2017]</span><div class="brieflinkpop offscreen_noflow">Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Michaud V, Lasseaux E, Plaisant C, Verloes A, Perdomo-Trujillo Y, Hamel C, Elcioglu NH, Leroy B, Kaplan J, Jouk PS, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pigment Cell Melanoma Res. 2017 Jan; 30(6):563-570. Epub 2017 Oct 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301410" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lewis RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301464" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301464" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042a8275f66d18aa03f445">Hermansky-Pudlak Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hermansky-Pudlak Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:35:30-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D20B2E0425EE100000000020E00C3&amp;ncbi_session=CE8D20B2E042A811_0526SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1287%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1287&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1287/&amp;ncbi_pagename=Hermansky-Pudlak Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D20B2E042A811_0526SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>